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SUMMARY 
The intestinal mucosa is a highly specialized surface epithelium with absorptive 
enterocytes, hormone-secreting endocrine cells, mucus-secreting goblet cells and 
antimicrobial peptides-producing Paneth cells. Intestinal epithelial cells (IECs) 
provide a physical barrier as well as innate immune defense, preventing the gut 
micobiota from entering host tissues. To control the large amount of microbiota, the 
epithelial lining critically depends on innate antimicrobial peptides and mucins. 
Disrupted intestinal homeostasis leads to inflammatory bowel disease (IBD) and 
intestinal tumorigenesis. Several molecular signaling mechanisms are necessary for 
intestinal homeostasis. Caspase-8 (Casp8) prevents intestinal epithelial cells from 
undergoing necroptosis and regulates cell proliferation. Notch and Hippo signaling 
control the cell fate determination between absorptive and secretoy cell lines. Active 
Notch promotes stem cell proliferation and inhibits secretory cell differentiation. 
Active Hippo signaling prevents cell proliferation and induces maturation of secretory 
cells.  
The current study focused on the regulatory effects of these three mechanisms on 
the intestinal epithelial differentiation. To analyze the effects of intestinal Casp8 
deficiency, in vivo and in vitro assays were performed using a Casp8 knockout 
(Casp8∆int) mouse model and Casp8-deficient Caco2 cell culture system. 
Loss of Casp8 in enterocytes induced increased stem cell-like population and 
inhibited secretory cell differentiation. Casp8∆int mice showed decreased mucosal 
antibacterial activity with loss of Paneth and goblet cells. This led to increased 
inflammatory response and changes in intestinal permeability. Consequently, 
Casp8∆int mice showed high mortality.  
By analysis of Casp8-Hippo interaction, we found up-regulated YAP levels, a target 
gene of Hippo signaling in Casp8∆int mice. This finding indicates that inactive Hippo 
signaling in Casp8∆int mice might lead to increasing cell proliferation, but inhibition of 
cell differentiation.  
In contrast, Notch signaling was active in Casp8∆int mice. Thus, we hypothesized that 
inhibition of Notch signaling could improve the outcome of Casp8 knockout mice by 
promotion of the intestinal mucosal barrier. To analyze this hypothesis, the 
functionality of the Notch signaling was pharmacologically modified using a gamma-
secretase inhibitor (GSI). Interestingly, Casp8∆int mice exhibited induced secretory 
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phenotype such as Paneth-like cells or goblet-like cells. Additionally Casp8-
dependent inflammatory activity was diminished. Intestinal permeability was 
significantly decreased and the survival rate of Casp8∆int mice was increased by 50%.  
Finally, Caco2 lacking Casp8 showed an increase in Notch activity and after GSI 
treatment, an increase in secretory phenotype was confirmed.  
In summary, Notch signalling modified Casp8-related functions in the intestine and 
inactivation of Notch reduced the Casp8 knockout-related disorders. Furthermore, the 
interactions between Notch and YAP via Casp8-dependent signaling are crucial for 
intestinal epithelium homeostasis. Therefore, these findings provide a valuable 
insight to understand the pathogenesis of IBD and carcinogenesis.  
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ZUSAMMENFASSUNG  
Die intestinale Schleimhautbarriere ist eine komplex aufgebaute Epithelzellschicht, 
die  aus Enterozyten, enteroendokrinen Zellen, Becherzellen, und Paneth-Zellen 
besteht. Sie vermittelt einen selektiven Schutz vor schädlichen luminalen 
Bestandteilen durch Freisetzung von protektiven Komponenten wie Mucinen und 
sekretorischen Immunglobulinen. Die Störung der intestinalen Homöostase führt zu 
chronisch-entzündlichen Darmerkrankungen und intestinaler Karzinogenese.  
Durch zahlreiche molekulare Signalkaskaden wird die intestinale Homöostase 
gesteuert. Caspase-8 (Casp8) verhindert eine Nekroptose von Enterozyten und 
reguliert die Zellproliferation. Die Notch- und Hippo-Signalkaskaden bestimmen, ob 
die Differenzierung in die absorptive oder sekretorische Richtung verläuft. Die 
Aktivierung des Notch-Signalwegs fördert die Proliferation von Stammzellen und 
inhibiert die Differenzierung von sekretorischen Zellen. Die Aktivierung der Hippo-
Signalkaskade verhindert die Stammzellproliferation und führt zur Differenzierung 
von sekretorischen Zellen. 
Die aktuelle Studie beschäftigt sich mit den Auswirkungen dieser drei Mechanismen 
auf die Differenzierung von intestinalen Epithelzellen. Die angesprochenen 
Auswirkungen wurden anhand eines in vivo und in vitro Moedlls analysiert. Zur in 
vivo Analyse wurde ein gewebespezifisches Casp8-Knockout-Mausmodell 
(Casp8Δint) erzeugt und etabliert. Als in vitro Modell dient die gut etablierte Caco2 
Zellkultur, die ursprünglich aus einem humanen Coloncarcinom isoliert worden ist.  
Mittels dieser Ansätze konnte gezeigt werden, dass der Verlust von Casp8 eine 
überproportionale Aktivierung von Notch mit Reduktion der sekretorischen 
Differenzierung bewirkt. Dies führte wiederum zu einer inadäquaten Kontrolle der 
bakteriellen Flora mit bakterieller Translokation und Entzündungsreaktion. Die 
intestinale Permeabilität war stark erhöht, was in eine signifikant erhöhte 
Mortalitätsrate der Casp8-Knockout-Mäusen resultierte.  
Durch Analyse der Casp8-Hippo-Interaktion, konnte eine Ü berexpression von YAP in 
Casp8Δint Mäusen nachgewiesen werden. Dies deutet auf eine Inaktivierung des 
Hippo Signalwegs in Casp8Δint Mäusen hin, was potentiell eine Steigerung der 
Zellproliferation und Hemmung der Zelldifferenzierung auslöst.  
Im Gegensatz dazu wurde, eine signifikante Expressionssteigerung von Notch in 
Casp8Δint Mäusen gefunden. Daher wurde die Hypothese aufgestellt, dass die 
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Hemmung des Notch-Signalwegs Casp8 vermittelte Entzündung reduzieren könnte. 
Um die funktionelle Relevanz einer Interaktion des Notch-Signalwegs mit Casp8 zu 
untersuchen, wurde den Tieren ein Gamma-Sekretase-Inhibitor (GSI) verabreicht. 
Interessanterweise wurde nach Verabreichung des GSI die Bildung der 
sekretorischen Phänotypen wie Paneth oder Becher-ähnlichen Zellen in Casp8Δint 
Mäusen induziert. Zusätzlich wurde die Casp8 vermittelte Entzündungsaktivität und 
die intestinale Permeabilität signifikant verringert. Die Ü berlebensrate der Mäuse 
erhöhte sich um 50%. Als abschließendes Experiment wurde der Knockdown von 
Casp8 in Caco2 untersucht mit dem Ergebnis, dass das Ausschalten von Casp8 zu 
einer Erhöhung der Notch Aktivität führte. Nach der Behandlung mit GSI konnte die 
Bildung von sekretorischen Phänotypen in dieser Zelllinie nachgewiesen werden.  
Zusammenfassend ergibt sich, dass der Notch-Signalweg essentiell an der 
Regulation der Casp8 relevanten Funktionen im Darm und die Inaktivierung von 
Notch eine Reduktion des durch den Casp8 Knockout bedingten Krankheitsbildes 
bewirkt. Ferner konnte festgestellt werde, dass die Wechselwirkungen zwischen 
Notch und YAP über den Casp8-abhängigen Signalweg entscheidend zur 
intestinalen Homöostase beitragen. Durch die Erkenntnisse dieser Studie konnte 
eine tiefere Einsicht in die Pathogenese von chronisch-entzündlichen 
Darmerkrankungen und der intestinalen Karzinogenese gewonnen werde. 
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1. Introduction 
1.1. The human gastrointestinal tract  
The human gastrointestinal tract (GIT) is divided into an upper and a lower part with 
specific functions controlled by the nervous and endocrine systems. The former 
includes mouth, pharynx, esophagus and stomach and involves the ingestion and 
digestion of food. The latter consists of the small intestine (duodenum, jejunum and 
ileum) and large intestine (colon and rectum). The absorption processes are subject 
to the small intestine. The large intestine facilitates water and final nutrient resorption 
(van der Flier and Clevers, 2009).  Even though the processes taking place in the 
different compartments are specialized, all compartments of the GIT have a similar 
fundamental structure consisting of four basic layers: from the outermost layer 
inwards the tunicae serosa, muscularis, submucosa and mucosa (Tortora and 
Derrickson, 2008). The mucosa represents the lining towards the lumen and has 
direct contact to the external environment. Its morphology is characterized by a 
specialized epithelium that is arranged into units of crypts, which invaginate into the 
epithelium, and units of villi, which extend like pillars above the epithelium. These 
structures increase the surface area of the intestine and allow for greater nutrient 
uptake. With respect to morphology, the difference between the small and large 
intestine is the absence of villi in the colon.  
 
 
1.2. Structure and function of the intestinal epithelium 
This intestinal epithelium, aside from having the capacity to absorb nutrients, also 
serves as a protective barrier composed of various proteins forming tight junctions 
between cells (Laukoetter et al., 2006). The intestinal epithelial layer is one of the 
most rapidly self-renewing tissues in the organism (van-Wetering et al., 1999; 
Gregorieff and Clevers, 2005). The mature intestine consists of differentiated cell 
types including enterocytes, enteroendocrine cells, goblet cells, and Paneth cells, 
which are all derived from the stem cells in the intestinal crypts (Crosnier et al., 2006; 
Bevins and Salzman, 2011). Each of these cell types has a specific function. The 
enterocytes are specialized absorptive cells containing microvilli. They constitute the 
majority of epithelial cells (~75%) in the small intestinal epithelium. Enteroendocrine 
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cells produce hormones for the regulation of the digestive system, affecting for 
example regulation of glucose homeostasis and gastrointestinal motility. Goblet cells 
produce and secrete mucus, a first barrier against the intestinal bacteria, but also 
have other beneficial functions for the repair of damaged epithelium (Crosnier et al., 
2006). Paneth cells, located at the base of the crypts, contribute to the innate 
immune system through the secretion of antimicrobial peptides (van der Flier and 
Clevers, 2009; Bevins, 2006). In contrast to the small intestine, Paneth cells are non-
existent and goblet cells show a strong presence in the large intestine. This 
increased presence of goblet cells allows for the development of a mucus layer from 
the cecum to the end of the GI tract at the rectum (Atuma et al., 2001). Figure 1.1 
shows the general structure and cell types of the intestinal epithelium.  
  
 
 
Figure 1.1. Intestinal epithelial homeostasis.  The architecture of adult intestine is 
characterized by the crypt-villus axis. In the crypt, the stem cells are lined with Paneth cells 
and give rise to progenitors/TA-cells. TA-cells differentiate into the mature cell types within 
their respective lineages (enterocytes, enteroendocrine cells, goblet cells, Paneth cells). The 
mature cells undergo apoptosis at the villus tip. Modified after Reichrath et al., 2012 
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All intestinal cell types descend from stem cells located at the base of the crypts. The 
adult stem cells self-renew and generate to daughter cells forming an adjacent zone 
of post-mitotic cells or proliferating transit amplifying progenitors (TA cells). The TA 
cells increase their pool to up to 300 cells per crypt per day before differentiating into 
multiple lineages. As part of their differentiation they migrate along the crypt-villus-
axis to the villus tip. Then, the differentiated cells undergo apoptosis at the villus tip, 
followed by shedding into the intestinal lumen. The migration process generally takes 
3-5 days (Crosnier et al., 2006; Barker et al., 2008). In contrast, Paneth cells do not 
migrate upwards, but downwards to the crypt base where they reside for about 20 
days before being phagocytosed by neighboring cells (Barker et al., 2008). The 
perinatal intestine does not have Paneth cells. They arise 2-3 weeks after birth 
(Leonard et al., 2012). This continuous replenishment of intestinal epithelium is 
important for the maintenance of epithelial integrity. The processes of intestinal 
development and maintenance are regulated by a complex balance of many 
signaling pathways including Notch, Wnt, Hippo, Hedgehog and Bone Morphogenetic 
Protein (Sancho et al., 2004; Radtke et al., 2005).  
 
 
1.3. Notch signaling in the intestine 
Notch signaling is active in intestinal crypt compartments and assists the Wnt 
pathway in promoting stem cell proliferation. Notch also promotes differentiation of 
intestinal absorptive cells and blocks differentiation of intestinal secretory cells 
indenpendently of Wnt (Fre et al., 2009). Notch signaling is thus essential for 
maintaining the intestinal development and homeostasis.  
In mammals, four Notch receptors and five ligands have been identified (Gordon et al. 
2008).  Both, the Notch ligands (Delta-like 1, 3 and 4; Jagged 1 and 2) and receptors 
(Notch 1-4) are trans-membrane proteins. Interaction of the Notch receptor and 
ligand between two neighboring cells initiates a series of receptor cleavage events. 
Although the four Notch receptors show some differences in their extracellular and 
cytoplasmatic domains, they have the same extracellular domain, epidermal growth 
factor (EFG)-like repeats, which participate in ligand binding. The N-terminal EGF-like 
repeats are followed by cysteine-rich Notch Linl2 repeats (N/Linl2) that prevent 
signaling in the absence of the ligand (Gordon et al., 2008).  
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During maturation, the Notch receptor is proteolytically cleaved at a site named S1 of 
Notch receptor by furin-like enzyme in trans-Golgi vesicles (Logeat et al., 1998). This 
cleavage results in two non-covalently associated extracellular and membrane-bound 
intracellular parts. Subsequently two rapid consecutive proteolytic events occur at 
sites designated as S2 and S3. The S3 cleavage is catalyzed by ADAM10, a 
metalloprotease TACE (tumor necrosis factor-alpha-converting enzyme) of the ADAM 
family, which removes the extracellular domain of the Notch receptor (Mumm and 
Kopan, 2000). A recent in vivo study confirms the catalysation of this essential 
cleavage by ADAM10 (Van Dussen et al., 2009). The released extracellular domain 
is trans-endocytosed by ligand-expressing cells. ADAM10-mediated cleavage 
produces a substrate for the γ-secretase complex-mediated S3 cleavage (Fortini et 
al., 2002). S3 cleavage is similar to the processing of the amyloid precursor protein 
(APP), which is associated with Alzheimer’s disease. As a result of the two proteolytic 
reactions at S2 and S3, the intracellular part of the Notch receptor (NICD) is released 
into the cytoplasm and then translocates into the nucleus of the signal-receiving cell. 
There, NICD binds to the transcription factor CSL in vertebrates (CBF1 in human, 
RBPJk in mice, Su(H) in Drosophila, Lag-1 in C. elegans), a DNA-binding protein, 
and to the transcriptional co-activator, Mastermind-like 1 (MAML1), which results in 
an activation of  target genes including hairy and enhancer of split 1 (Hes1) (Lubman 
et al., 2004). This activation promotes the differentiation of absorptive cells in the 
intestine (van der Flier and Clevers, 2009; Scoville et al., 2008). Conversely, in the 
absence of NICD, the transcriptional regulator CSL appears to occupy its DNA 
binding sites and participate in a repressor complex (Kopan et al., 2009). The 
transcription factor Math1 is a downstream target of Hes1 repression in the intestine. 
Its activity leads to generation of the secretory cell lineages (Ueo et al., 2012). Math1-
null mice show a complete absence of any secretory cell types in the intestine (Yang 
et al., 2011). 
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Figure 1.2. The Notch signaling pathway. (A) Schematic representation of Notch 
receptors and ligands. (B) Molecular mechanisms of the Notch signaling pathway. S1 
indicates cleavage of nascent Notch receptors by a furin-like convertase. S2 indicates ligand-
induced cleavage of Notch receptors at an extracellular membrane site by ADAM 10 
metalloproteases, and S3 indicates S2-dependent cleavage of Notch receptors within the 
trans-membrane domain by γ-secretase. Upon binding of Notch receptors to trans-
membrane ligand, S2 cleavage releases the extracellular domain of the Notch receptor, 
which is endocytosed together with the ligand. S3 cleavage releases the Notch intercellular 
domain (NICD), which translocates into the nucleus, where it activates transcription. NICD 
binds to CSL and recruits co-activators (Co-A) like MAML1 to activate transcription of target 
genes such as Hes1. NICD is ubiquitinated by Fbw7 to target it for degradation. 
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1.4. Notch in the differentiation of intestinal secretory cell lineage  
1.4.1. Characterization of the secretory progenitor cell 
Differentiation of an intestinal progenitor to a mature secretory cell must involve the 
progenitor cell becoming competent for the secretory cell fate. However, it is currently 
not well understood how progenitor cells are specified to a specific secretory cell 
lineage. Some recent studies suggest that Math1 and some Notch-mediated 
transcription factors including Neurog3, Gfi1 and Spdef are the critical factor for 
specification to the secretory lineage (Yang et al., 2001; Shroyer et al., 2007). 
Neurog3 is necessary for specification of enteroendocrine cells (Lee et al., 2002; 
Jenny et al., 2002; Lopez-Diaz et al., 2007). In contrast, the transcription factors 
growth factor independent 1 (Gfi1) and SAM pointed domain ETS factor (Spdef) have 
been identified as downstream targets of Math1 (Shroyer et al., 2005). Gfi1 is a zinc-
finger transcriptional repressor that plays an important role in the regulating of 
proliferation and differentiation in hematopoietic stem cells and immune cells 
(Kazanjian et al., 2006). Gfi1-deficient mouse intestinal epithelium is characterized by 
a loss of Paneth cells, decreased goblet cells and increased enteroendocrine cells 
suggesting that Gfi1 functions to select the goblet/Paneth versus enteroendocrine 
cell fates (Shroyer et al., 2005). In addition, a mouse model deficient in Spdef 
expression had impaired maturation of both goblet and Paneth cells (Gregorieff et al., 
2009). However, the early goblet cell marker, Tff3 was expressed on a normal level 
and enteroendocrine cell number was unchanged in this model (Gregorieff et al., 
2009). Transgenic mice expressing intestinal Spedf also shows decreased epithelial 
proliferation without apoptosis and increased goblet cell gene expression at the 
expense of other secretory cell lineages (Noah et al., 2010). These data suggest that 
mutation of Spdef affects terminal differentiation of both goblet and Paneth cells. 
Furthermore, there are some more genes in the intestine which are expressed in both 
Paneth and goblet cells e.g. serine/threonine kinase 11 (STK11), cAMP responsive 
element binding protein 3-like 4 (Creb3l4), chemokine (C-C motif) ligand 6 (Ccl6), 
kallikrein 1 (Klk1), and serine peptidase inhibitor, Kazal type 4 (Spink4) (Noah et al., 
2010; Shoming et al., 2009). These results indicate that Paneth and goblet cells may 
share a common progenitor of differentiation.  
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1.4.2. Goblet Cell Differentiation 
Intestinal goblet cells secrete mucin glycoproteins.  Their major component is Muc2, 
which protects the intestinal epithelium and serves as a medium for transport 
between the luminal contents and epithelial cells. The colon shows the highest 
number of goblet cells when compared to the small intestine and its mucin layer is 
much thicker (Kemper et al., 1991; Deplancke et al., 2001). The intestinal mucins are 
mostly acidic and characterized by a blue staining with periodic acid Schiff-alcian 
blue (PAS-AB) compared to the stomach which consists of neutral mucins that are 
characterized by a pink or red staining with PAS-AB. The mucus secretion and the 
type of mucins expressed can be modulated by host-microbial interactions 
(Deplancke et al., 2001). Kruppel-like factor 4 (KLF4) is a zinc finger transcription 
factor, which is an important regulator of goblet cell differentiation in the intestine 
(Shields et al., 1996; Katz et al., 2002; McConnell et al., 2007). In a recent study, with 
HT29 human colon cancer cells KLF4 expression has been reported to be regulated 
by Notch signaling. Increased KLF4 expression was observed when Notch signaling 
was inhibited with DBZ and decreased KLF4 expression was observed when Notch 
was active (Ghaleb et al., 2008).  
 
 
1.4.3. Paneth Cell Differentiation  
Paneth cells are highly specialized and located at the base of the small intestinal 
crypts of Lieberkühn. They are absent from the colon under normal conditions, but 
they can be induced in the colon in adenocarcinoma (Gibbs, 1967; Andreu et al., 
2005). Paneth cells produce antimicrobial peptides (AMPs) including human α-
defensin-5 and -6, cryptdins (mice), procryptdin precursors MMP7, lysozyme, RegIIIγ, 
and sPLA2 (Ouellette et al., 2004; Wehkamp et al., 2006; Ayabe et al., 2002; Bevins, 
2004; George et al., 2008). Mature Paneth cells appear in the mouse small intestine 
at 2-3 weeks of age, concomitant with crypt formation. Even though Paneth cells 
appear to be the same throughout the small intestine, cryptdin genes expression is 
different depending on intestinal colonization. For example, cryptdin-4 expression is 
restricted to Paneth cells of the distal small intestine whereas cryptdin-1 and -5 are 
expressed throughout the intestine (Ouellette et al., 1994; Ouellette et al., 2004). 
Several studies suggest that Wnt signaling is essential for Paneth cell maturation and 
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distribution. Wnt targeted Sox9 gene expression increases the expression of a 
number of Paneth cells. Paneth cells were found to be absent in Sox9-deficient mice 
(Mori-Akiyama et al., 2007; Bastide et al., 2009). Other factors including MMP7, 
EphB3, Csf1, PPAR have also been shown to be involved in Paneth cell 
differentiation (van ES et al., 2005; Varnat et al., 2006; Huynh et al., 2009).  
 
 
 
Figure 1.3. Model of cell fate specification in the intestine. Stem cells are regulated 
by Notch and Wnt. Notch signalling selects the absorptive over secretory cell fates through 
the lateral inhibition. Secretory progenitor may be differentiated into enteroendocrine 
progenitor or goblet/Paneth progenitor.  
 
 
1.5. Notch signals in intestinal tumors 
The oncogenic potential of Notch signals and the relationship between Notch and 
intestinal tumors have been reported in many studies. Hes1, a signature of Notch 
signal activation, is over-expressed in mouse adenomas (APCmin/+ mice) (van Es JH 
et al., 2005; Veenemdaal et al., 2008) and in human colorectal cancer (CRC) 
(Fernandez-Majada et al., 2007; Sikandar et al., 2010), whereas Math1 is down-
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regulated in CRC samples (Bossuyt et al., 2009). These finding indicated that Notch 
signaling is abnormally activated in colorectal cancer (CRC) and its inhibition is able 
to suppress the cancer cell growth and induce cancer cell apoptosis (Pannequin et 
al., 2009; Masahiro et al., 2010). Indeed, in vitro treatment of human colon cancer 
cells such as LS174T, HT29 and HCT116 with γ‑secretase inhibitors (GSI) reduces 
proliferation, induces apoptosis and secretory cell lineage differentiation (Ghaleb et 
al., 2008; Okamoto et al., 2009; Sikandar et al., 2010). Therefore, a study of the role 
of γ‑secretase in the Notch signaling activation has suggested the potential use of 
GSI in the treatment of colon cancer (Harper et al., 2003; Miele et al., 2006; Roy et 
al., 2007). Moreover, Notch signaling has been proposed as an important target for 
the treatment of other pre-malignant conditions in the gut, such as Barrett’s 
esophagus and inflammatory bowel diseases (Okamoto et al., 2009; Menke et al., 
2010). 
 
 
1.6. Structure and function of γ-secretase inhibitors   
The γ-secretase is a protein complex composed of the AD-associated presenilin (PS), 
nicastrin (NCT), alphaprotein-1 (Aph-1) and presenillin enhancer-2  homolog (Pen2) 
(Sato et al., 2007). The γ-secretase inhibitors (GSIs) have been developed as 
inhibitors of γ-secretase-mediated cleavage and downstream signaling events. 
Recently there has been an increasing interest in using GSIs as anti-cancer drugs 
because they could potentially block hyperactive Notch signaling driving cancer 
progression. Dibenzazepine (DBZ), one of the γ-secretase inhibitors, has been 
reported to inhibit epithelial cell proliferation and induce goblet cell differentiation in 
intestinal adenomas in mice (van ES JH et al., 2005). In addition, animals treated 
with the other GSI such as benodiazepine (BZ), or LY-411,575 showed intestinal 
goblet cell hyperplasia of the phenotype observed in Notch disruption models (Milano 
et al., 2004; Wong et al., 2004).  
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Figure 1.4. Chemical structure of the γ-secretase inhibitor Dibenzazepine (DBZ) 
 
 
1.7. Caspase-8 
Caspase-8 (Casp8) belongs to the family of cysteine proteases that are known as cell 
apoptosis initiators (Degterev et al., 2003). In human, Casp8 maps to chromosome 
2q33 and is evolutionary highly conserved (Kischkel et al., 1998). This enzyme is a 
55kDa protein of 480 amino acids and exists as inactive proenzyme, composed of a 
prodomain, a large and a small protease subunit. Two death-effector-domains (DED) 
are located at the N-terminus, which function as platforms for protein-protein 
interaction (Barnhart et al., 2003). Upon proteolytic activation at the C-terminal 
aspartic residues, Casp8 generates an active heterodimeric form with two large and 
two small subunits (Degterev et al., 2003).  
There are two different caspase-8-dependent apoptosis pathways: the death receptor 
(extrinsic) pathway and the mitochondrial (intrinsic) pathway (Fulda and Debatin, 
2006). The death receptor pathway is initiated at the cell surface by binding of death 
receptor ligands such as Fas ligand (FasL), tumor necrosis factor-alpha (TNF-α), or 
TNF-related apoptosis-inducing ligand (TRAIL) to specific death receptors. This 
process recruits certain adaptor molecules to form the death-inducing signaling 
complex (DISC) consisting of Fas-associated protein with death domain (FADD) and 
pro-Casp8 (Nagata et al., 1997; Reed et al., 2000; Ashkenazi et al., 2008). After 
Casp8 is activated, it can directly cleave effector caspases such as caspase-3 
(Nicholson, 1999; Kumar, 1999). The intrinsic pathway begins at the mitochondria 
from intracellular stressors including DNA damage, oxidative stress and endoplasmic 
reticulum stress (Becker et al., 2013). Activation of Casp8 can indirectly promote 
effector caspase activation by cleaving the BH3-interacting death agonist (Bid), which 
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is a pro-apoptotic protein of the Bcl-2 family and plays a crucial role in the release of 
proapoptotic proteins like cytochrome c and Smac/DIABLO into the cytosol 
(Ashkenazi et al., 2008; Adams and Cory et al., 2007; Zermati et al., 2007). In the 
cytosol, caspase-3 is activated by forming the apoptosome complex with apoptotic 
protease activating factor (Apaf-1), caspase-9 and cytochrome c (Zermati et 
al.,2007). These data suggest that the inactivation of Casp8 cannot induce apoptosis 
and this provides the opportunity for carcinogenesis (Krelin et al., 2008).  
Besides its key role in the regulation of apoptosis, Casp8 also has non-apoptotic 
functions. Casp8 in neuroblastoma cell lines plays a role in mediating focal adhesion 
complex formation and cellular migration (Stupack et al., 2006; Barbero et al., 2009; 
Torres et al., 2010). In addition, Casp8 controls T cell proliferation via control of IL-2 
generation and B-cell activation (Algeciras-Schimnich et al., 2002; Launay et al., 
2005).                                                                                                               
Recently, it has been reported that Casp8 prevents an alternative mode of cell death 
termed necroptosis (Gunther et al., 2011). It is associated with intestinal inflammation 
through specific activation of TNF-α synthesis by RIP3. The intestinal epithelia cell-
specific Casp8 knockout mice showed intestinal inflammation with loss of Paneth 
cells and reduced goblet cell numbers, which is similar to Chron’s disease in human 
(Gunther et al., 2011; Wittkopf et al., 2013). This process can contribute to regulation 
of immune system and plays a role in cancer development (Wu et al., 2012). 
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Figure 1.5. The central role of caspase-8 in apoptosis and necroptosis. Casp8 
mediate extrinsic and intrinsic apoptosis. The extrinsic pathway is triggered by death receptor 
ligands such as TNF-α, which bind their receptor. The activated receptor forms a signaling 
complex, which recruits FADD and pro-Casp8, leading to activation of Casp8. Activated 
Casp8 cleaves Casp3 and this process leads to the apoptosis. The intrinsic pathway is 
induced at the mitochondria by cellular stress. Casp8 cleaves Bid and forms tBid (truncated 
Bid). This mechanism causes release of Cyto c (cytochrome c), which activates Casp9. 
Activated Casp9 leads to apoptotic processing. Necroptosis occurs when apoptosis signaling 
pathways are inhibited, such as when Casp8 are blocked. Inactivation of Casp8 induces 
necroptosis by the phosphorylation and activation of RIP1 and RIP3.  
 
 
1.8. Inflammatory bowel disease 
Inflammatory bowel disease (IBD) is characterized by recurring immune response 
and inflammations in the intestinal tract with abdominal pain, diarrhea, ulcerations 
and fistulas (Podolsky, 2002). Additional histological features like a distorted 
epithelial architecture, lymphocyte and plasma cell infiltrate, crypt abscesses, and 
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basal lymphoid aggregates are used to distinguish chronic IBD from other cases of 
intestinal inflammations (Le et al., 1995). The pathogenesis of IBD is very complex 
and they include genetic susceptibility, environmental factors, and the host’s immune 
response (Sartor et al., 2003). Environmental factors may be smoking, alcohol, drug 
and infectious agents. The genetic defects in intestinal epithelium can induce 
abnormal activation of the immune system in the intestine and cause intestinal 
inflammation (Cominelli, 2004; Barrett et al., 2008; Corridoni et al., 2014). Several 
studies also have reported that a defective innate immune response within the 
intestinal mucosa is a primary contributor (Mike et al., 2007). Dysfunction of the 
intestinal epithelium has been shown to be a dominant pathway in IBD (Corridoni et 
al., 2014). Thus, epithelial permeability defects can lead to intestinal inflammation 
(Benais-Pont et al., 2003). Indeed, IBD patients have an increase in intestinal 
paracelluar permeability and defects in the regulation of tight junctions (Meddings et 
al., 1994; Schmitz et al., 1999). The classical IBD includes two major forms of chronic 
intestinal disorders: Crohn’s disease (CD) and ulcerative colitis (UC). The main 
difference between CD and UC is the affected area of the gastrointestinal tract. CD 
can occur in any part of the digestive tract and spread deep into the bowel wall 
(mucosa, submucosa, serosa). In contrast, UC usually only affects the top layer of 
the colon and rectum (mucosa, submucosa). CD is often segmental, while UC results 
in connected inflammation. Fistulas are common in CD and allow rarely bacteria from 
the intestine to infect other organs causing illness.  
 
 
1.8.1. Crohn’s disease  
CD is a chronic inflammation of uncertain etiology that can occur anywhere along the 
lining of the digestive tract. The classification sub-phenotypes CD according to the 
affected gastrointestinal location: Small intestine (L1), colon and/or rectum (L2) and 
both, small and large intestine (L3). Ileocolitis affects the ileum and the colon, while 
Ileitis only affects the ileum and colitis only affects the colon. Disease progression 
states can range from a weak inflammatory, non-stricturing and non-penetrating (B1), 
to a stricturing (B2), or a penetrating (B3) course with internal fistulae (Gasche et al., 
1998; Louis et al., 2001; Silverberg et al., 2005). In recent years, many studies have 
demonstrated defective antimicrobial defenses as major pathogenic mechanisms in 
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CD, e.g. reduced expressions of human β-defensins-1, -2 and -4 in CD patients with 
colonic involvement (Wehkamp et al., 2003; Nuding et al., 2007; Kapel et al., 2009). 
Ileal CD is characterized by a significant decrease of the small intestinal AMPs and 
human α-defensin-5 and -6, which are produced in Paneth cells (Ouellette et al. 
,2004; Wehkamp et al., 2006; George et al., 2008).  
 
 
1.8.2. Ulcerative colitis  
Ulcerative colitis is a disease that causes inflammation in the lining of the rectum and 
colon. Proctitis only affects the rectum, while pancolitis affects the entire colon. In 
addition, proctosigmoiditis involves inflammation of the rectum and the colon 
(Kornbluth et al., 2010). The classical symptoms range from abdominal pain, bloody 
diarrhea, fever, and loss of body weight. UC patients are at increased risk of colon 
cancer and children with UC can fail to develop properly (Farrell and Peppercorn, 
2002).  
 
 
Table 1.1. Histological comparison of Crohn’s disease versus Ulcerative colitis 
 Crohn’s disease Ulcerative colitis 
Location Any part of GIT 
Most common: Ileocolitis  
Colon, rectum 
Histology Discontinuous inflammation 
Lymphoid aggregates  
Granulomas  
Transmural inflammation 
Continuous inflammation 
Ulceration  
Goblet cell mucin depletion 
 Mainly mucosal inflammation 
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1.9. Aim of this study 
The intestinal epithelium consists of a single layer of intestinal epithelial cells that 
provides a physical barrier as well as an innate immune defense. Secretory 
antimicrobial agents and mucins from Paneth cells and goblet cells provide the first 
defense barrier between gut microbiota and intestinal epithelium. Thus, defects in 
epithelial barrier and immune functions contribute to the etiology of inflammatory 
bowel disease (IBD). Several conserved signaling pathways are associated with the 
maintenance of the morphological and functional features of diverse epithelial cell 
types. In particular, Notch and Hippo signaling pathways are involved in controlling 
and determining the cell fate of intestinal stem cells.  
Casp8 is a critical initiator of extrinsic apoptosis, as well as a suppressor of cell death 
termed necroptosis in the intestine. A deficiency of Casp8 in the intestinal epithelium 
showed inflammation phenotype with loss of Paneth cells and reduced goblet cell 
numbers similar to those of Chron s´ disease (Gunther et al., 2011).  
These data suggest Casp8, Notch and Hippo signaling to be potential key pathways 
in the regulation of the intestinal barrier and to contribute to inflammatory intestinal 
diseases like IBD or Chron s´ disease. The aim of the present study was to 
investigate the relationship between Casp8 and Notch signaling in the regulation of 
intestinal homeostasis and inflammation. 
In a Casp8 knockout mouse model, we analyzed the modification of intestinal 
secretory cell lineage and epithelial expression of key genes participating in innate 
immunity in the gut. Furthermore, we evaluated whether Notch pathway was involved 
in intestinal Casp8 knockout phenotype and if this cross-talk had a potential impact 
on intestinal host defense. Additionally, the role of epithelial specific Hippo/YAP 
signaling in Casp8 deficient intestine was investigated.  
Understanding the interactions between Casp8-dependent molecular mechanisms 
and intestinal barrier function might provide an important insight into the 
pathogenesis of intestinal bowel diseases and colorectal cancer. 
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2. Materials and methods 
All chemicals were of the highest purity grade available and obtained from regular 
commercial suppliers. For preparation of buffers and solutions a high-purity Milli-Q-
Water (Millipore, Schwalbach) was used, designated as ddH2O.  
 
 
2.1. Materials 
2.1.1. Laboratory equipments 
Blotting Trans-Blot Semi-dry                                     Biorad, Munich 
Centrifuge 5417R                                                      Eppendorf, Hamburg                                     
Milli-Q  system                                                           Millipore, Schwalbach 
DNA electrophoresis apparatus                     Serva, Heidelberg 
Fluorescence microscope Eclipse 80i                        Nikon, Düsseldorf 
Gel chamber Blot System Mini Protean III                 Biorad, Munich 
IQ5 Real-time PCR equipment                               Biorad, Munich 
LCM microscope (Carl Zeiss)                                    Carl Zeiss, Munich 
Nanodrop ND-1000                                                    Peqlab, Erlangen 
Optimax X-ray film developer                               Protec medical systems, Gronau 
Paraffin embedding station Histocenter 2                  Thermo Scientific, Karlsruhe 
Phase contrast microscope Axiovert 25                     Zeiss, Jena  
pH meter 766 Calimatic                                              Knick, Berlin 
Thermomixer compact 5436                                       Eppendorf, Hamburg 
Tissue homogenizer Ultra Turrax                      IKA Labortechnik, Staufen 
Ultracut microtome RM2145                                Leica Microsystems, Wetzlar 
Ultrasonic homogenizer Sonoplus                              Bandelin Electronic, Berlin 
UV Gel analysis equipment                      Intas, Goettingen 
Veriti Thermal Cycler                                                  Applied Biosystems, Darmstadt 
Vortex Reax top                                                          Heidolph, Schwabach 
 
     
2.1.2. Software 
Graph Pad Prism                                                        La Jolla/CA, USA 
ImageJ                                                                        Wayne Rasband/NIH, USA 
IQ5 Standard edition                                                   Biorad, Munich 
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Nano ND-1000                                                            Peqlab, Erlangen 
Tecan i-control Fluormeter Software                           Tecan, Cailsheim 
 
 
2.1.3. General material 
Adhesive cap tubes 500µl                                          Carl Zeiss, Munich 
Blotting paper                                                              Biorad, Munich 
Chemiluminescence film                                             GE Healthcare, England 
Cover glasses                                                              Langenbrinck, Emmendingen 
Dako Pen                                                                     Dako, Hambrug 
Embedding cassettes                                                  Thermo Scientific, Karlsruhe 
Gewebekulturflaschen T75                                         Greiner bio-one, Frickenhausen 
Hematocrit capillary tubes                                           Hirschmann Laborgeraete 
Histoslides adhaesiv                                                   Thermo Scientific, Karlsruhe 
Immobilon-P Transfer membrane                                Millipore, Schwalbach 
Injection needles Sterican                                           Braun, Melsungen 
Microseal B Sealing film                                              Biorad, Munich 
Multiwell-plates qRT-PCR                                           PeqLab, Erlangen 
Multiwell-plates black                                                  Becton Dickinson, Karlsruhe 
polyethylene naphthalate (PEN)-coated slides           Carl Zeiss, Munich 
Surgical Instruments                                                    FST, Heidelberg 
Steel feeding tubes                                                      Henry Schein VET, Hamburg 
 
 
2.1.4. Chemicals and solvents 
Acetate                                                                         Sigma-Aldrich, Steinheim 
Acetone                                                                        Roth, Karlsruhe  
Agarose (Electrophoresis grade)                                 Roth, Karlsruhe  
6-Aminohexan acid                                                      Roth, Karlsruhe 
Ammonium acetate                                                      Sigma-Aldrich, Steinheim 
β-Mercaptoethanol                                                       Merck, Darmstadt 
Boric acid                                                                     Roth, Karlsruhe 
Bromophenol Blue                                                       Bio-Rad, Munich 
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BSA (Bovine Serum Albumin)                                      Sigma-Aldrich, Steinheim 
Calciumchloride                                                           Sigma-Aldrich, Steinheim 
Chloroform                                                                   Sigma-Aldrich, Steinheim 
Cresyl violet                                                                  Merck, Darmstadt  
DEPC (Diethyl pyrocarbonate)                                     Roth, Karlsruhe 
DBZ (Dibenzazepine)                                                   Institute of Organic Chemistry,  
                                                                                     RWTH Aachen 
DMSO                                                                          Roth, Karlsruhe                                           
DTT (Dithiothreitol)                                                      Sigma-Aldrich, Steinheim 
EDTA (Ethylene diamine tetraacetate)                        Serva, Heidelberg 
Entwickler G153                                                           AGFA, Köln 
Eosin                                                                            Sigma-Aldrich, Steinheim 
Ethanol                                                                         Roth, Karlsruhe 
Ethidium bromide                                                         Invitrogen, Karlsruhe 
Fixierer G354                                                                AGFA, Köln 
FITC-dextran (4kDa)                                                    Sigma-Aldrich, Steinheim 
Formaldehyde (Formafix, 4 %)                                     Patho Med Logistic, Viersen 
Glutaraldehyde 25%                                                     Agar Scientific/Planto, Wetzlar 
Glycine                                                                         Roth, Karlsruhe 
Guanidine hydrochloride                                              Roth, Karlsruhe 
Haematoxylin                                                                Merck, Darmstadt 
Hydrochloric acid                                                          Merck, Darmstadt 
Hydrogen peroxide                                                       Roth, Karlsruhe 
Isopropyl alcohol                                                          Sigma-Aldrich, Steinheim 
Magnesium chloride                                                     Sigma-Aldrich, Steinheim 
Methanol                                                                       Roth, Karlsruhe 
Methocel○R  E4M                                                             Sigma-Aldrich, Steinheim 
Non-fat dry milk powder                                                Roth, Karlsruhe 
OCT Tissue-Tek compound                                          New York, USA 
Sodium chloride                                                             Merck, Darmstadt 
Sodium dihydrogen phosphate                                      Roth, Karlsruhe 
SDS (Sodium dodecylsulfate)                                        Roth, Karlsruhe 
Sulfuric acid                                                                   Roth, Karlsruhe 
Paraffin (Histoplast)                                                       Thermo Scientific, Karlsruhe 
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RNAlater ICE                                                                Invitrogen, Darmstadt 
Rotiphorese○R  10x SDS PAGE                                    Roth, Karlsruhe 
TEMED (Tetramethylethylendiamine)                          Roth, Karlsruhe 
TRIzol                                                                           Sigma-Aldrich, Steinheim 
Tris                                                                                Roth, Karlsruhe 
Tween○R  20                                                                  Sigma-Aldrich, Steinheim 
Tween○R  80                                                                  Sigma-Aldrich, Steinheim 
Urea                                                                              Roth, Karlsruhe 
VECTASHIELD Mounting Medium                               Vector laboratories/CA, USA 
Vitro-clud Mounting Medium                                         Langenbrinck, Emmendingen 
Xylene                                                                           Fischar, Saarbruecken 
 
2.1.5. Buffers and reagents 
2.1.5.1. Buffer for gel electrophoresis 
 
TBE (50x)               Reagents   Volume 
Tris 108g 
Boric acid     55g 
EDTA(0,5M  pH8,0) 40mL 
 ad 1L 
    
2.1.5.2. Buffer for SDS-PAGE and Western Blot 
 
Anode buffer I/II (10x)               Reagents   Volume 
Tris 36,5g (I) / 365g (II) 
 ad 1L 
 
Blocking buffer              Reagents   Final concentration 
TBST  1x 
non-fat milk powder  
or BSA 
5%  
 
Cathode buffer           Reagents   Volume 
Tris 30,2g 
6-Aminohexan acid 50,25g 
 ad 1L 
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LE buffer pH8,8 (10x)               Reagents   Volume 
Tris 108g 
Glycine 144g 
 ad 1L 
 
 
TBST pH7,5         Reagents   Volume 
1M NaCl 30mL 
1M Tris pH7,5 20mL 
Tween○R  20    0,5mL 
 ad 1L 
 
 
2.1.5.3. Buffer for Immunohistochemistry and Immunofluorescens 
      
     Citrate buffer  pH 6,0           36ml solution A + 164ml solution B 
                                                  ad 2L 
 
 
Stock solution A               
Reagents   Volume 
Citric acid 21,01g 
 ad 1L 
 
Stock solution B           Sodium citrate       29,41g 
 ad 1L 
  
 
 
PBS (10x)        Reagents   Final concentration 
KCl 30mM 
KH2PO4   15Mm 
NaCl   1,37M 
Na2HPO4 2H2O      65mM 
 ad 1L 
 
TBS Reagents   Final concentration 
Tris 0,02M 
NaCl 0,9% 
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2.1.5.4. Genotyping lysis buffer 
 
Mouse tail lysis buffer Reagents   Final concentration 
Tris-HCl pH8,0 1M 
EDTA pH8,0 0,5M 
NaCl 1M 
SDS  1% 
Proteinase K 15,4 mU 
 
 
2.1.5.5. Cell culture medium and additives 
EMEM                                                                         Lonza, Steinheim 
Fetal Bovine Serum 10%, certified                              Invitrogen, Karlsruhe 
L-Glutamine, 1,6mM                                                    PAA, Coelbe 
Non-essential amino acids                                          Gibco, USA 
Penicillin 40000 U/ml, Streptomycin 40mg                  PAA, Coelbe 
Sodium pyruvate                                                         Gibco, USA 
 
 
2.1.6. Molecular biological reagents, enzymes and kits 
2.1.6.1. Reagents for siRNA Knockdown  
Lipofectamine 2000™                                                  Invitrogen, Darmstadt 
Opti-MEM○R                                                                  Invitrogen, Darmstadt  
siRNA sample buffer                                                    Qiagen, Hilden 
Trypsin                                                                         Invitrogen/Gibco, Darmstadt 
 
 
2.1.6.2. Reagents for PCR, cDNA-Synthese, RealtimePCR and gel 
eletrophoresis 
DNAse I                                                                       Roche, Mannheim 
DNAse reaction buffer                                                 Roche, Mannheim 
DNA Loading dye, 6x                                                  New England Biolabs, Frankfurt 
1kb DNA Ladder                                                          New England Biolabs, Frankfurt 
IQ5 SYBR Green Supermix                                         Biorad, Munich 
Low Molecular Weight DNA Ladder                            New England Biolabs, Frankfurt 
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Protector RNAse inhibitor                                            Roche, Mannheim 
Proteinase K                                                                Appli Chem, Darmstadt 
RedTaq○R ReadyMixTMPCR                                         Sigma-Aldrich, Steinheim 
Reverse Transcription system kit                                 Promega, Mannheim 
RNeasy micro Kit                                                         Qiagen, Hilden 
 
 
2.1.6.3. Reagents for Protein isolation, SDS-PAGE and Western Blot 
Benzonase                                                                  Roche, Mannheim 
BioRad Dc Protein Assay Reagent A                          BioRad, Munich 
BioRad Dc Protein Assay Reagent B                          BioRad, Munich 
BioRad Dc Protein Assay Reagent S                          BioRad, Munich 
Complete Mini Proteaseinhibitor                                 Roche, Mannheim 
ECL Western Blotting Substrate                                 Thermo Scientific, Karlsruhe 
Laemmli sample buffer, 2x                                          Sigma-Aldrich, Steinheim 
PeqGold prestained Protein marker V                        Peqlab, Erlangen 
Supersignal West Femto Substrate                            Thermo Scientific, Karlsruhe 
Western blot stripping buffer                                       Thermo Scientific, Karlsruhe 
 
 
2.1.6.4. Reagents for Immunohistochemistry and Immunofluorescence 
Antibody Diluent                                                          Nichirei/ Medac, Wedel 
DAB Peroxidase Substrate Kit                                    Vector, USA 
DeadEndTM Fluorometric TUNEL System                 Promega, Madison 
MOM immunodetection Kit                                          Vector, USA 
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2.1.7. Primer 
Table 2.1. Primer sequences used for quantitative real-time PCR 
Gene Primer Sequence in 5’-3’ orientation Product size 
human 
Cyclophilin 
sense CATTTGCCATGGACAAGATG 300 bp 
antisense ACCCCACCGTGTTCTTCGAC 
human 
Hes1 
sense TCAACACGACACCGGATAAA 152 bp 
antisense CCGCGAGCTATCTTTCTTCA 
human 
Math1 
sense CCGCCCAGTATTTGCTACAT 234 bp 
antisense CATTCACCTGTTTGCTGGAA 
human 
MMP7 
sense GAG TGC CAG ATG TTG CAG AA 169 bp 
antisense AAA TGC AGG GGG ATC TCT TT 
human 
Tff3 
sense CAG CTT TTC TGT CCC TTT GC 156 bp 
antisense CAC GAC GCA GCA GAA ATA AA 
mouse 
Agn4 
sense TCA GCA CTA TGA TGC CAA GC 204 bp 
antisense GTG GTG ATC TGG AAG GGA GA 
mouse 
Cryptdin-1 
sense GCA CAG AAG GCT CTG CTC TT 229 bp 
antisense ACC CAG ATT CCA CAT TCA GC 
mouse 
Cryptdins 
sense AGGAGCAGCCAGGAGAAG 192 bp 
antisense ATGTTCAGCGACAGCAGAG 
mouse 
GAPDH 
sense GGTCGGTGTGAACGGATTTGGCCG 238 bp 
antisense GTTAGTGGGGTCTCGCTCCT 
mouse 
GCNT3 
sense CTA ACA GGA GCC TGG GTG AG 181 bp 
antisense TGG TAC CTT CTT GGC TGC TT 
mouse 
Gfi1 
sense AGG AAC GCA GCT TTG ACT GT 169 bp 
antisense CCT GTG TGG ATG AAG GTG TG 
mouse 
Hes1 
sense CTACCCCAGCCAGTGTCAAC 170 bp 
antisense ATGCCGGGAGCTATCTTTCT 
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mouse 
IL-1ß  
sense GCC CAT CCT CTG TGA CTC AT 230bp 
antisense AGG CCA CAG GTA TTT TGT CG 
mouse 
KLF4 
sense TGATGGTGCTTGGTGAGTTG 210bp 
antisense TTGCACATCTGAAACCACAG 
mouse 
lysozyme 
sense ATGGAATGGCTGGCTACTATGGAG 259 bp 
antisense CTCACCACCCTCTTTGCACATTG 
mouse 
Math1 
sense GCTTCCTCTGGGGGTTACTC 170bp 
antisense CTGTGGGATCTGGGAGATGT 
mouse 
MMP7 
sense CCC GGT ACT GTG ATG TAC CC 164 bp 
antisense AAT GGA GGA CCC AGT GAG TG 
mouse 
Mucin2 
sense CTA GTG GTG GAA GCC AGC TC 191 bp 
antisense CCA GCT ATT CCC AAA GTC CA 
mouse 
Tff3 
sense TCT GGC TAA TGC TGT TGG TG 212 bp 
antisense CTC CTG CAG AGG TTT GAA GC 
mouse 
TNFa 
sense CAGTCTGCAGGGAGTGTGAA 197bp 
antisense CACGCACTGGAAGTGTGTCT 
 
 
Table 2.2. Primer sequences used for genotyping of Casp8∆int mice 
Gene Primer Sequence 
in 5’-3’ orientation 
Annealing 
Temperature 
Product 
size 
Cre 
recombinase 
sense CCACGACCAAGTGACAGCAAT 57 °C 392 bp 
antisense TTCGGTCATCAGCTACACCA 
WT 
Casp8 allele 
sense CATACTGGTTGAGAACAAGACC
TGG 
60 °C 660 bp 
antisense GCAGAGGTGACAAGAGGCCACT
G 
Floxed 
Casp8 allele 
 
sense AACTTCGGCCGGCCAATAACTT
CG 
60 °C 
 
 
1100 bp 
 
 antisense AGCAGAAAAACTTGAAGAAACTT
GG 
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2.1.8. Antibodies 
Table 2.3. Primary and secondary antibodies used for Western blot and 
Immunhistochemistry  
Primary antibody Manufacturer Usage 
ß- Aktin (rabbit) Sigma-Aldrich, Steinheim WB, 1:1000 
Calnexin (rabbit) Santa Cruz Biotech, Hamburg WB, 1:1000 
Caspase8 (mouse) Alexis/Axxora, Loerrach WB, 1:1000 
cleaved Muc2 (rabbit) Biozol, Eching WB, 1:1000 
GAPDH (mouse) AbD Serotec, Duesseldorf WB, 1:1000 
GCNT3 (goat) Santa Cruze Biotech, Hamburg WB, 1:1000 
Lysozyme (rabbit) Dako, Hamburg IHC, 1:2000 
Mucin2 (rabbit) 
YAP (rabbit) 
Phosphor-YAP (Ser127) (rabbit) 
Santa Cruz Biotech, Hamburg 
Cell signaling, USA 
Cell signaling, USA  
IHC, 1:500 
WB, 1:1000 
WB, 1:1000 
 
Secondary antibody Manufacturer Usage 
Anti-mouse IgG HRP Santa Cruz Biotech, Hamburg WB, 1:10000 
Anti-goat IgG HRP Santa Cruz Biotech, Hamburg WB, 1:10000 
Anti-rabbit IgG HRP Santa Cruz Biotech, Hamburg WB, 1:10000  
 
2.1.9. siRNA  
Table 2.4. siRNAs used for transfection 
siRNA Function Manufacturer Sequence  
Hs Casp8_7 Specific 
knockdown 
of Casp8 
expression 
Qiagen, Hilden 5’-GUUCCUGAGCCUGGACUACTT-3’ 
5’-GUAGUCCAGGCUCAGGAACTT-3’ 
Hs Casp8_12 
5’-CAAAGUUUACCAAAUGAAATT-3’ 
5’-UUUCAUUUGGUAAACUUUGTC-3’ 
Allstars 
Negative Control 
siRNA 
Scrambled 
siRNA 
Qiagen, Hilden  
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2.1.10. Animal and eukaryotic cell line 
2.1.10.1. Caspase-8 knockout mouse model 
To induce Caspase-8 knockout mice (Casp8∆int) were used genetically modified mice 
carrying loxP recombination sites in intron 2 and 4 of the murine Casp8 gene in a 
C57/BL6 background as described (Liedtke et al., 2011). These animals (Caspf/f 
mice) were crossed with Cre-transgenic mice expressing a Cre-transgene under 
control of the villin promoter (Pinto et al., 1999) to generate intestinal epithelium-
specific constitutive Casp8 homozygous knockout mice (Casp8∆int). Cre-negative-
Casp8+/loxP and villin-Cre mice were kindly provided by PD. Dr. C. Liedtke (University 
Hospital Aachen, Medical Clinic III) and Dr. med. G. Sellge, Ph.D. (University 
Hospital Aachen, Medical Clinic III), respectively.  Casp8∆int mice were generated by 
our group Dr. A. Reinarzt and Dr. M. Adolf (Institute of Pathology, University Hospital 
Aachen). Animal experiments were performed with Casp8∆int mice of male gender 
and as controls cre-negative littermates (Casp8f/f) were used. For genotyping of 
genetically modified mice, tail biopsies were taken after ear marking and subjected to 
genomic DNA extraction and subsequent PCR analysis according to standard 
procedures (Chapter 2.4.3). 
 
Mouse line Genotype Gender 
of mouse 
Function 
B6-tg(VillCre)(Casp8-P) Casp8Δint m enterocyte-specific Casp8 
homozygous knockout 
B6-tg(VillCre)(Casp8-P) 
Casp8f/f m cre-negative littermates 
C57/Bl6  m controls 
 
2.1.10.2. Human cell culture model 
Strain Source Reference 
Caco2 Human colon adenocarcinoma Fogh et al., 1975 
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2.2. Molecular biological Methods 
2.2.1. Extraction of total RNA from tissues and cells  
RNA extraction from mouse intestine and Caco2 cells was carried out based on the 
protocol of the Chmoczynski method (Chomczynski and Sacchi, 1987). 30mg 
intestine tissue and 105 cells were incubated with 1mL TRIzol reagent. Tissues were 
homogenized with an electric homogenizer and cells were detached from 6-well plate 
using a cell scraper. Each sample of tissue or cell suspension in TRIzol was 
transferred into a sterile 2mL microcentrifuge tube and 200µl of chloroform added. 
The mixture was vortexed for 15 seconds and incubated at RT for 10 minutes. The 
sample was centrifuged at 12000rpm and 4°C for 15 minutes and the upper clear 
aqueous RNA phase was transferred into another sterile 2ml microcentrifuge tube. 
1ml isopropanol was added into the RNA phase and after mixing the sample was 
incubated at RT for 10 minutes. RNA was pelleted by centrifugation at 12000 rpm 
and 4°C for 15 minutes. The RNA pellet was washed with 500 µL of 80% ethanol and 
centrifuged again at 10000rpm and 4°C for 5 minutes. The pelleted RNA was air 
dried and eluted in 40µL of DEPC-treated water. The RNA was quantified 
spectrophotometrically at 260 nm by Nanodrop ND-1000 (PeqLab) and purity 
estimated by absorbance ration at 260/280.  
 
 
2.2.2. cDAN synthesis using reverse transcription 
To remove DNA contamination of the RNA sample it was performed DNAse digestion 
step. 5µg RNA was incubated in DNAse-free buffer and DNAse I (10000 U) at 37°C 
for 1,5 hours and then at 75°C for 10 minutes according to the manufacturer’s 
protocol. Single-stranded RNA was converted into double-stranded DNA (cDNA) for 
use as a template for PCR amplification. Reverse transcription was carried out using 
Reverse Transcription system kit (Promega) following the manufacturer’s instruction. 
The generated cDNA was used for quantitative realtime PCR (qRT-PCR) or 
alternatively stored at -20°C.  
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2.2.3. Primer-design and quantitative realtime PCR 
The primer-design was carried out using Software Primer design tool of Eurofins 
MWG and Pimer was synthesized under controlling of various parameters, i.e. the 
length of primer (18- 28 bp), the GC contents (50-60%), Primer dimmer avoidance 
and prevention of mRNA secondary structure. Annealing temperature of each primer 
was tested and qRT-PCR was done with these PCR parameters. qRT-PCR was 
performed using IQ5 detection system (BioRad) and a SYBR Green PCR Kit 
(Invitrogen). Reactions were done in duplicate in a total volume of 20µl with 40 
cycles. After PCR reaction, relative mRNA expression values were calculated 
according to the ∆∆ct method (Pfaffl et al., 2001) in comparison to a calibration 
sample, which was derived from control. GAPDH or cyclophilin were used as 
housekeeping genes for analysis. A list of PCR primers used in this study and details 
for the conditions of established qRT-PCR are given in Table 2.1 and Table 2.5.  
 
 
Table 2.5. Established conditions of qRT-PCR 
Reagents for qRT-PCR Reaction program for qRT-PCR 
Reagent Volume  
[µl] 
Step Temperature [°C] Time No. of 
cycle 
cDNA 1 Initial 
denaturation 
95 5 min 1 
SYBR Green Mix 10 Denaturation 95 15 sec  
sense primer 
(10µM) 
1 Annealing depends on the 
Tm of the primer 
15 sec 40 
antisense primer 
(10µM) 
1 Elongation 72 20 sec 1 
ddH2O 7 Melting curve 55 
55 to 95 
1 min 
15 sec 
 
89 Total volume 20 
 
 
 
2.3. Laser capture microdissection (LCM) 
Laser capture microdissection (LCM) allows direct microscopic visualization of tissue 
sections and the isolation of specific cell populations for DNA, RNA, and protein 
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profiling. To facilitate cutting, slides covered with a polyethylene napthalate (PEN)-
membrane, which acts as stabilizing scaffold during cutting.  
Frozen mouse intestine was embedded in OCT (Tissue-Tek), cut at 18 μm thickness 
and mounted on polyethylene naphthalate (PEN)-coated slides (Carl Zeiss). The 
frozen sections were incubated in RNAlater ICE (Invitrogen) for overnight and fixed in 
a series of ethanol with decreasing concentrations (each for 30s in 95%, 75%, and 
50% ethanol). The sections were stained with 0,1% (w/v) alcohol-based cresyl violet 
solutions for 10 s. The sections were dehydrated in graded ethanol solutions (eas for 
30s in 50%, 75%, 95%, 100%) and cleared in xylene (5 min). After air-drying for 10 
min, 2 - 4 x 105 villus and crypts were microdissected into 500µl adhesive cap tubes 
(Carl Zeiss) using the RoboLPC function of a PALM MicroBeam LCM microscope 
(Carl Zeiss). Total RNA was extracted from the captured cells using the RNeasy 
micro Kit (Qiagen). Samples were reverse transcribed and subjected to qRT-PCR 
analysis as described Chapter 2.2.3. 
 
2.4. Animal experimental methods 
2.4.1. Animal maintenance and treatments 
Animals were bred and maintained in a facility of the University Hospital RWTH 
Aachen in a temperature-controlled room with 12 hours light/dark cycles and free 
access to standard food and water. All experiments were performed in accordance 
with the German legislation on protection of animals and approved by the 
government of the state North Rhine-Westphalia (LANUV, AZ 84-02. 04. 2013. A034).  
 
 
2.4.2. Isolation of genomic DNA from a tail tip biopsy 
A tail tip biopsy was incubated overnight in 750 µl of lysis buffer (Chapter 2.1.5.4), 
supplemented with 20µl proteinase K at 56°C shaking in a Thermomixer at 1000rpm. 
The solution was centrifuged at 12000 g for 10 minutes. 500µl of supernatant 
containing DNA was transferred in a new microcentrifuge tube and precipitated with 
500µl isopropanol. After centrifugation at 12000 g for 10 minutes at 4°C, the 
supernatant was discarded and the pellet was washed twice with 500µl of 70% 
ethanol. The drying pellet was dissolved in 100µl ddH2O and incubated in a 
Termomixer at 300rpm, for 1 hour at 37°C. Isolated DNA was quantified using 
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spectrophotometery (Nanodrop ND-1000, PeqLab) and DNA concentration was 
calculated based on absorption at 260nm. For PCR applications, 10ng or 50ng DNA 
was used per 25µl reaction.  
 
 
2.4.3. Genotyping 
For determining the Casp8 knockout of mice, three different PCR reactions per 
sample, specific for cre-recombinase, the WT and the floxed Casp8 allele, 
respectively, were performed using the primer as listed in Table 2.2. PCR was 
performed using Red Taq Mastermix (Sigma) according to manufacturer’s 
instructions with 30 cycles and an annealing temperature of 60°C or 57°C. 
Identification of the PCR reaction was done by analyzing the PCR product on an 
agarose gel. The conditions of established PCR genotyping are given in Table 2.6. 
  
Table 2.6. Established conditions of PCR genotyping  
Reagents for PCR Reaction program for PCR 
Reagent Volume  
[µl] 
Step Temperature [°C] Time No. of 
cycle 
DNA (10ng) 1 (or 5) Initial 
denaturation 
95 3 min 1 
RED Taq Mix 12,5 Denaturation 95 1 min  
sense primer 
(10µM) 
1,25 Annealing 60 (or 57) 1 min 30 
antisense primer 
(10µM) 
1,25 Elongation 72 1 min  
ddH2O 9 (or 4) Final elongation 72 3 min 1 
Total volume 25 Hold 4 until 
analysis 
 
( ), for Cre-recombinase PCR 
 
 
2.4.4. Treatment of animals with γ-secretase inhibitor Dibenzazepine 
To inhibit Notch signaling it was used a type of γ-secretase inhibitor Dibenzazephine 
(DBZ). DBZ was kindly provided by Prof. Dr. M. Niggemann (Institute of Organic 
Chemistry, RWTH Aachen University). DBZ solubilized in DMSO was suspended in 
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PBS containing 0,5% (w/v) hydroxypropylmethylcellulose (Methocel E4M, Sigma) 
and 0,01% (v/v) Tween 80. A dose of DBZ 20 µM/kg body weight was injected 
intraperitoneally (i.p.) into male mice at 3-4 week of age. The serial treatment of DBZ 
was taken pro two days for 10 days and mice were sacrificed. Their organs were 
subjected to histological and molecular analysis. The control animals received a 
corresponding volume of vehicle alone. Whole body weights of mice were measured 
every 2 days.  
 
 
2.4.5. Intestinal permeability assay 
Intestinal permeability was assessed using mice that received oral gavage of FITC-
dextran (4kDa, Sigma). FITC-conjugated dextran dissolved in water was 
administered rectally to mice at 2mg/10g body weight. Whole blood was collected 
using hematocrit capillary tubes via eye bleed 1 hour and 4 hours after FITC-dextran 
administration. Fluorescence intensity in serum was analyzed using a plate reader. 
The concentration of FITC-dextran in serum was determined by comparison to the 
FITC-dextran standard curve.  
 
 
2.5. Cell biological and biochemical methods 
2.5.1. Cultivation of Caco2 Cells 
In this work used human colon adenocarcinoma Caco2 cell line which is a model of 
differentiating colonic epithelial cells. Caco2 cells were grown in EMEM medium 
(Lonza) supplemented with 10% (v/v) Fetal bovine serum (Invitrogen), 1% (v/v) non-
essential amino acids (Gibco), Sodium pyruvate (Gibco) and 1% (v/v) penicillin-
streptomycin (P/S) and at 37°C in an atmosphere of 5% CO2. Cells were passaged 
when being 80% confluent. Cells were gently washed 1 time with 1X PBS, trypsinized 
until being detached, resuspended in growth medium, pelleted by centrifugation at 
2000 rpm for 5 minutes, resuspended again in  growth medium and sub-cultured at a 
concentration of 30% in a new T75 flask. Alternative selections of cell growth medium 
were used in the experiments of siRNA transfection and DBZ treatment and 
supplementation, which are described in the next chapter.  
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2.5.2. Transfection with small interfering RNA  
Transient transfection delivers genetic material such as siRNA into eukaryotic cells 
so that the genetic material is expressed in the cells for a few days. In this study, 
siRNAs were designed to knockdown the expressions of human Caspase-8 genes, 
and commercially synthesized (Qiagen). As control, a scrambled negative siRNA that 
is not homologous with any human mRNA transcripts was also synthesized (Qiagen). 
Details of the siRNA are given in Table 2.4. For transfection 105 Caco2 cells were 
seeded in each well of a 6-well plate and each well contained 2ml modified cell 
growth medium containing EMEM supplemented with 10% (v/v) FBS, 1% (v/v) non-
essential amino acids, Sodium pyruvate and no P/S. 20pmol siRNA or scrambled 
control siRNA was mixed gently with 500µl Optimem in a universal tube and the 
mixture was dripped into one well containing cells. Then 5µl Lipofectamine 2000™ 
was added into the each well and mixed gently, followed by incubation at RT for 15 
minutes.  After being added into the well and diluted in the total 2.5ml medium, the 
20pmol siRNA resulted in working concentrations of approximately 7,5nM. Cells 
treated with the transfection mix were grown for 48 hours at 37°C in an atmosphere 
of 5% CO2 and then the medium was replaced. 
 
 
2.5.3. Treatment of Caco2 with γ-secretase inhibitor Dibenzazepine 
After Casp8 knockdown using siRNA, Caco2 cells were treated with DBZ. DBZ in 
DMSO was diluted in PBS containing 0,5% (w/v) Methocel E4M (Sigma) and 0,01% 
(v/v) Tween 80 and was used at 10µM. Control cells were treated with the vehicle. 
Cells were further grown for 48 hours and total RNA and protein lysis were harvested. 
 
 
2.6. Protein chemical methods 
2.6.1. Extraction of total protein from tissues and cells  
The Protein isolation using TRIzol was identical carried out the RNA extraction until 
phase separation (Chapter 2.2.1) and the pink colored organic phase (protein phase) 
was used for further protein extraction. After addition of 1,5 ml isopropanol to the 
protein phase was mixed gently and incubated at RT for 10 minutes. Protein was 
precipitated at 120000 rpm and 4°C for 10 minutes and the pellet was then washed 
with 2mL of 0.3M Guanidine-HCL in ethanol. Protein pellet was incubated at RT for 
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20 minutes and centrifuged again at 1000rpm and 4°C for 5 minutes. This washing 
step was performed two times and finally the pellet was washed again with 100% 
ethanol. After air drying of pellet, it was dissolved in 250µl 7,5M Urea/1,8M DTT 
containing Proteinase-inhibitor and incubated at RT for at least 1 hour. Finally the 
protein lysate was sonicated for 10 seconds with a 50% pluse using a sonicator and 
then heated at 95°C for 5 minutes. Protein was quantified (Chapter 2.6.2) and stored 
at -80°C before use.  
  
 
2.6.2. Measurement of protein concentration 
The protein concentration was determined by UV-spectroscopy using Biorad Protein 
Assay reagent. This assay is based on the absorbance maximum of Coomassie 
Brilliant Blue G-250, which the absorption maximum shifts from 465nm to 595nm 
after protein binding. According to manufacturer’s instructions, proteins and BSA 
standards were measured at OD595 and the OD595 values of protein samples were 
then calculated by comparison with the absorption of the BSA standard curve.  
 
 
2.6.3. SDS-PAGE and Western blot 
Protein samples were separated electrophoretically on sodium dodecyl sulphate 
(SDS) polyacrylamide gels regarding to their molecular weights. Low concentration 
gels (7,5% or 10%) were used to separate large protein molecules, whereas high 
concentration gel (12%) was used to separate small protein molecules. Gels and 
buffer were prepared according to standard protocol (Table 2.7) and a Mini-Protean 
III cell (Biorad) was used as electrophoresis equipment.  For each sample, 20µg 
protein lysate was mixed with 2x Protein loading buffer in a ration of 1:1 (v/v) and 
boiled at 95°C for 5 minutes before loading on the gel. The electrophoresis was 
carried out at 130V until the dye front reached the bottom of the gel. PeqGold 
prestained protin marker (Peqlab) was used to estimate protein molecular weight.  
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Table 2.7. Protocol for SDS-PAGE 
Reagent Volume for 2 minigels 
 
Stacking gel 
7,5% 10% 12% 
Resolving gel Resolving gel Resolving gel 
Acrylamide/ 
Bisacrylamide 
2,5ml 0,75ml 3,3ml 4,0ml 
Stacking  
or Resolving gel buffer 
2,5ml 1,25ml 2,5ml 2,5ml 
ddH2O 4,95ml 2,9ml 4,2ml 3,4ml 
10% APS 45µl 30µl 45µl 45µl 
TEMED 12,6µl 20µ 12,6µl 12,6µl 
 
For immunological detection, the separated proteins on the gel were transferred onto 
a polyvinylidene difluoride (PVDF) membrane using a semi-dry blotting chamber 
(Biorad) according to standard procedures. Briefly, a membrane was activated with 
methanol and the gel washed in cathode buffer. At the same time a sheet of 
Whatman filter paper was immersed in anode buffer I, II and cathode buffer, 
respectively. The gel was placed upon a membrane and two sets of three pieces of 
Whatman filter papers were placed on top of the gel and at bottom of the membrane. 
Transfer was carried out at 210mA and RT for 45 minutes. After transfer of the 
proteins, the membrane was incubated in TBST pH 8,0 containing 5 % (w/v) non-fat 
milk powder or alternatively containing 5% BSA at RT for 1 hour. This allows 
preventing non-specific binding of the proteins to the membrane. Next, the 
membrane was incubated with the primary antibody at RT for 1 hour and then at 4°C 
overnight. The membrane was washed 6 times with TBST, each time for 5minutes 
and then incubated for 1 hour with the secondary horseradish-peroxidase (HRP) 
conjugated antibody diluted 1/10000 (v/v) in 5% (w/v) milk- or BSA-TBST. Antibodies, 
which did not bind to primary antibodies, were washed out 6 times with TBST, each 
time for 5 minutes. Detection was carried out using a chemiluminescence reaction, 
which luminol is oxidized by the peroxidase that is coupled to the secondary 
antibodies. The membrane was incubated in ECL Substrate (Thermo Scientific) for 5 
minutes and the fluorescent signal was captured on x-ray film. 
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2.6.4. H&E, Alcian blue PAS and Naphthol AS-D Chloroacetate esterase stain  
For this study, tissue samples from animals were performed Hematoxylin and eosin 
(H&E), Alcianblue/PAS (Periodic acid Schiff) or Naphthol AS-D Chloroacetate 
esterase staining by the routine working group from the Institute of Pathology, 
University Hospital RWTH Aachen, according to their standard protocol. H&E stains 
are essential for recognizing various tissue types and their morphologic changes. 
While the alkaline hemalaun stains the nuclei in a blue tone, the acidic eosin 
component stains eosinophilic structures red. The combined Alcianblue/PAS 
technique is used for the demonstration of mucosubstances. The PAS demonstrates 
the presence of glycogen and neutral mucosubstances by staining tissues pink-red, 
whereas the Alcian blue (pH 2,5) reaction demonstrates the presence of acidic 
mucins by staining them blue. Chloroacetate esterase stain was used to identify 
enzyme activity of neutrophilic granulocytes and mast cells. Naphthol AS-D 
Chloroacetate is enzymatically hydrolyzed by esterase, librating a naphthol. Then this 
reacts with a diazonium salt, forming red colored deposits at sites of enzyme activity 
of granulocyte.  
 
 
2.6.5. Immunohistochemistry 
Paraffin embedded sections were deparaffinised with xylene (3x 5 minutes) and 
rehydrated with decreasing ethanol concentrations (each for 2x 5 minutes in 100%, 
96%, and 70% ethanol). Alternatively, heat induced antigen retrieval was performed 
in sodium citrate buffer pH 6,0 for 10-15 minutes. After cooling for 15 minutes at RT, 
sections were treated with 3% H2O2 for 15 minutes to inhibit the reaction of 
endogenous peroxidase, followed by washing steps 6 times for 5 minutes with TBST. 
Sections were blocked in 2,5% normal horse serum (NHS) for 30 minutes and 
washed again with TBST. The primary antibody was diluted in 2,5% NHS and applied 
for 1 hour at RT or overnight at 4°C. Slides were washed with TBST for 3x5 minutes 
and then incubated with HRP conjugated secondary antibody (Immpress rabbit) for 1 
hour at RT. After washing 6 times for 5 minutes with TBST, the signal was developed 
with a diaminobenzidine (DAB) and the sections was counterstained with 
Hematoxylin. The tissue was dehydrated again in increasing ethanol concentrations 
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(each for 5 minutes with 700%, 96 and 100% ethanol) and transferred to xylene for 
10 minutes. Finally the slides were mounted with Vitro-Clud.   
  
 
2.6.6. Immunofluorescence 
TUNEL (TdT-mediated dUTP nick end labeling) is to detect nuclear DNA fragment of 
apoptotic cells by catalytically incorporating fluorescein-12-dUTP(a) at 3 -´OH DNA 
ends using terminal Deoxynucleotidyl Transferase (TdT) and the fluorescein-12-
dUTP-labeled DNA is then visualized by fluorescence microscopy. For TUNEL 
analysis, the DeadEndTM Fluorometric TUNEL System (Promega) was used and 
performed according to the manufacturer’s instructions. Paraffin embedded sections 
(4µm) from mouse intestine were deparaffinised with xylene and rehydrated with 
decreasing ethanol series (each for 3 minutes in 100%, 95%, 85%, 70% and 50% 
ethanol). After washing sections with 0,85% NaCl and PBS for 5 minutes, the tissue 
sections were fixed in 4% paraformaldehyde solution in PBS for 15 minutes, followed 
by two washes in PBS. To enhance the tissue’s permeability, sections were 
incubated in Proteinase K solution by diluting 1/500 in PBS at 37°C for 10 minutes. 
Sections were washed with PBS and fixed again in 4% paraformaldehyde for 5 
minutes. After washing with PBS, sections were stained with TUNEL mix for 1hour at 
37°C. Slides were washed in PBS, stained with DAPI and mounted in 
VECTASCHIELD Mounting Medium (Vector). 
 
 
2.7. Statistical analysis 
Statistical analysis was performed with GraphPad Prism version 5,0 (GraphPad 
Software Inc.) using the Kaplan-Meier analysis, the one-way or two-way ANOVA and 
the Mann-Whitney U-test. A P-value less than 0,05 was considered significant. All 
data are presented as mean ±SEM. 
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3. Results 
 
3.1. Characterization of Casp8∆int mice  
 
3.1.1. Macroscopical analysis of Casp8∆int mice  
 
In order to investigate the role of Casp8 in the gut, experiments were done using 
knockout mice with constitutive deletion of Casp8 specifically in intestinal epithelial 
cells (Casp8∆int mice). Mice carrying floxed Casp8 alleles were cross-bred with mice 
carrying the Cre-recombinase under control of the Villin-promotor (Chapter 2.1.10). 
First, the impact of intestinal Casp8 deficiency on body weight and survival rate was 
examined. The depletion of Casp8 in intestinal epithelial cells showed a significant 
phenotype. As shown in Figure 3.1, Casp8∆int mice steadily lost weight from 3-week 
old compared to control littermates (Casp8f/f mice). Ultimately, the 5-6 week old 
Casp8∆int mice displayed high mortality. These findings are associated with intestinal 
phenotype of Casp8∆int mice (Chapter 3.1.2).  
 
 
Figure 3.1. Casp8∆int mice showed continuous weight loss, thereby leading to 
death. (A) Survival analysis of Casp8∆int and control Casp8f/f mice (n=4/group). (B) Average 
body weight of Casp8∆int mice and control littermates (n=5/group). 
 
 
 
3.1.2. Intestinal morphology in Casp8∆int mice 
Histological analysis of Casp8∆int mice revealed a disorganized intestinal morphology 
including the destruction of the crypt-villus architecture, the loss of intestinal secretory 
cells and the expansion of undifferentiated stem/progenitor cells. This tissue 
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destruction was accompanied by an extensive inflammatory cell infiltration. (Fig.3.2-
A). The intestinal inflammation of Casp8∆int mice was also assessed by qRT-PCR 
analysis of mRNA expression of pro-inflammatory cytokines such as TNF-α and IL-
1β. In consistence with histological analysis, both TNF-α (2-fold) and IL-1β (6-fold) 
were significantly increased in small intestine of Casp8∆int mice compared to control 
littermates (Fig.3.2-B). Furthermore, intestinal inflammation was observed throughout 
the entire intestine, including the colon. In the colon, epithelium of Casp8 deficient 
mice increase rates of cell death was found (Fig. 3.2-A). 
 
 
 
Figure 3.2. Abnormal intestinal morphology in Casp8∆int mice. (A) H&E staining 
showed the destruction of crypt-villus architecture, crypt abscesses, infiltration and cell death 
in small intestine or/and colon of Casp8∆int mice (scale bar 200 µm; inset shows single crypt 
at higher magnification x63, scale bar 30 µm; arrow indicates cell death). (B) mRNA 
expression of pro-inflammatory cytokines TNF-α and IL-1β in Casp8 deficient intestine. 
Values were normalized to GAPDH expression (means ± SEM; n=3/group; **p<0,01; 
***p<0,001).  
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3.1.3. Decreased secretory cell development in Casp8 deficient intestine 
3.1.3.1. Loss of Paneth cells in Casp8∆int mice  
To take the normal regional variation in secretory cell numbers along the anterior-
posterior gut axis into consideration, analysis of cellular changes induced by Casp8 
included six separate regions: duodenum, jejunum, proximal and terminal ileum, 
proximal and distal colon. 
In Casp8∆int mice, H&E staining showed loss of Paneth cells throughout the small 
intestine, which was confirmed by staining with lysozyme (Fig. 3.3-A). Correlating 
with loss of lysoyzme-positive cells, protein levels of another Paneth cell marker 
calnexin was also decreased in Casp8∆int intestine (Fig. 3.3-B). To confirm this 
finding, the intestinal expression of key genes involved in Paneth cells was further 
measured by qRT-PCR. This analysis revealed down-regulation of lysozyme, 
cryptdins and procryptdin precursors MMP7 in Casp8∆int compared to control mice. 
Cryptdin-1 mRNA was significantly decreased in Casp8∆int mice with decreases up to 
11-fold in the jejunum and 9-fold in the terminal ileum. In addition, Casp8∆int mice 
exhibited a 4-fold decrease in Agn4, a marker of bactericidal ribonuclease in the 
proximal colon (Fig. 3.3-C). These results indicate that Paneth cell numbers decrease 
in the small intestine in strong correspondence to Casp8 deficiency.  
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Figure 3.3. Loss of the Paneth cells in the small intestine of Casp8∆int mice. (A) 
Casp8∆int and Casp8f/f intestine sections were stained with H&E and lysozyme for the Paneth 
cells (scale bar 200 µm; inset shows single crypt at higher magnification x63, scale bar 30 
µm; arrows indicate crypt bottom with Paneth cells). Some background staining (lysozyme, 
brown) was observed in the lamina propria. (B) Expression of antimicrobial genes was 
measured by Western blot (calnexin) and (C) qRT-PCR analysis (cryptdin-1, cryptdins 
(cryptdin1-4), Agn4, MMP7, lysoyzme) of small intestine and colon from Casp8∆int mice and 
control littermates. All markers were down-regulated in Casp8 deficient mice. Values were 
normalized to GAPDH expression and reported as fold-change relative to control. n. d.: not 
determined (means ± SEM; n=3 mice/region; *p<0,05; **p<0,01; ***p<0,001). 
 
 
 
3.1.3.2. Reduction of intestinal goblet cells in Casp8∆int mice 
Next, goblet cells, another cell type belonging to the intestinal secretory lineage were 
examined. Similar to the Paneth cell findings, the reduction of goblet cells was 
observed in all six regions of the intestine. H&E staining showed decreased numbers 
of goblet cells in the intestine of Casp8∆int mice, which was confirmed by staining with 
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the mucus-specific Alcian blue/PAS and anti-Muc2 (Fig. 3.4-A). Western blotting for 
Muc2 demonstrated significant decreases in goblet cell number in the small intestine 
of Casp8∆int mice compared to Casp8∆f/f mice (Fig. 3.4-B). The mRNA expression of 
goblet cell markers such as Muc2, GCNT3, Tff3 and KLF4 was found to be down-
regulated in Casp8 deficient intestine. Casp8∆int mice exhibited a 32-fold decrease in 
Muc2 in the distal colon and a 68-fold decrease in GCNT3 in the terminal ileum. 
Additionally, mRNA levels of Tff3 were 4-fold lower in the terminal ileum of Casp8∆int 
mice compared to control littermates (Fig. 3.4-C).  
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Figure 3.4. Reduction of goblet cell numbers throughout the intestine of 
Casp8∆int mice. (A) Alcian blue/PAS staining and Muc2 immunostaining (brown) of 
intestine showed decreased numbers of goblet cells in Casp8∆int compared to Casp8f/f mice 
(scale bar 200 µm). (B) Western blot for Mucin-2 expression. Muc2 expression significantly 
showed decreased goblet cell numbers throughout the gut of Casp8∆int mice. Values were 
normalized to GAPDH expression (means ± SEM; n=3 mice/region; ***p<0,001). (C) qRT-
PCR analysis of goblet cell markers (Muc2, GCNT3, Tff3 and KLF4) mRNA abundance in the 
intestine. Decreased expression of goblet cell markers in Casp8 deficient intestine was 
observed. Values were normalized to GAPDH expression and reported as fold-change 
relative to controls (means ± SEM; n=2-3 mice/region; *p<0,05; **p<0,01).  
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3.1.4. Increased intestinal permeability in Casp8∆int mice 
Our data presented in Chapter 3.1.2 and 3.1.3 showed an up-regulation of pro-
inflammatory cytokines, a down-regulation of antimicrobial peptides and mucin 
production as well as an extensive inflammatory cell infiltration in the intestine of 
Casp8∆int mice. These findings suggest an alteration of the immune response and 
also intestinal permeability in Casp8∆int mice. 
To assess this hypothesis, the changes in intestinal permeability were investigated 
via FITC-dextran analysis. Casp8∆int mice were orally gavaged with fluorescein 
isothiocyanate-dextran (FITC-dextran, 4 kDa) and assessed the translocation of 
FITC-dextran from the gut lumen into the serum.  
As a result, a significant increase in the amount of FITC-dextran in the serum of 
Casp8∆int mice compared to control littermates was observed. After 1-hour 
administration of FITC-dextran, FITC levels were 4-fold increased in Casp8∆int mice 
when compared with Casp8∆f/f mice. Furthermore, intestinal permeability to FITC was 
7-fold higher in Casp8∆int mice than in controls after 4 hours (Fig 3.5). These results 
demonstrate that intestinal Casp8 deficiency is associated with a significant increase 
in permeability of the intestine. 
  
 
 
Figure 3.5. Intestinal permeability is significantly higher in Casp8∆int mice. 
Casp8∆int mice showed increased FITC-dextran flux across the intestinal mucosa compared 
to control littermates. (means ± SEM; n=3 mice/group; ***p<0,001; ****p<0,0001) 
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3.2. Notch signaling in Casp8∆int mice 
Activation of intestinal Notch signaling directs progenitor cells toward an enterocyte 
fate at the expense of secretory fates. This mechanism results in a loss of secretory 
lineage in the intestinal epithelium, including goblet and Paneth cell markers (Fre et 
al., 2005; Stanger et al., 2005). Hes1 is known to be a transcriptional target of active 
Notch signaling, with expression localized to the epithelial progenitor zone of the 
intestine. Conversely, Math1 is a repressor of Hes1 and Math1 expression is required 
for intestinal secretory cell development (Schroder et al., 2002; Yang et al., 2001; 
Shroyer et al., 2007).  
To test whether the Notch signalling pathway contributes to the observed reduction in 
secretory cell differentiation in Casp8∆int mice, the mRNA expression levels of Hes1 
and Math1 were analysed. Total Hes 1 mRNA was increased throughout the gut of 
Casp8∆int mice with increases up to 1,8-fold in the proximal ileum and 1,9-fold in the 
terminal ileum. Conversely, the mRNA expression of Math1 was down-regulated in 
the small intestine and colon of Casp8∆int mice compared to control littermates, but it 
was not statistical significant (Fig. 3.6-A). 
To further understand the Notch mechanism leading to reduced secretory cells in the 
intestine of Casp8∆int mice, the above results were compared to Hes1 mRNA levels in 
isolated and separated into intestinal cell populations. Two cell populations were 
isolated through laser capture microdissection (LCM), one from crypts 
(undifferentiated cells) and one from villi (terminally differentiated cells). As expected, 
Hes1 mRNA levels were higher in the basal crypt cell population than in terminally 
differentiated cells. Additionally, the expression of Hes1 mRNA in the crypt of 
Casp8∆int mice was slightly increased compared to controls, but not significant (Fig. 
3.6-B). These data suggest a possible role of active Notch signaling in regulating 
differentiation of secretory lineage in Casp8 deficient intestine. 
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Figure 3.6. Up-regulation of Notch activity in Casp8∆int. (A) qRT-PCR analysis of 
Math1 mRNA abundance in the small intestine and colon showed decreased expression 
levels in Casp8∆int mice compared to controls (but n.s.). In contrast, Hes1 expression was 
significantly increased in the small intestine of Casp8∆int mice. Values were normalized to 
GAPDH expression and reported as fold change compared to control (means ± SEM; n=3 
mice/region; **p<0,01; ****p<0,0001). (B) Comparison by qRT-PCR of Notch marker 
expression in microdissected crypt and villi populations. mRNA levels of Hes1 gene were 
measured by qRT-PCR on differentiated (villi) and undifferentiated (crypt) cells isolated by 
laser capture microdissection (LCM) from Casp8f/f and Casp8∆int intestine (scale bar 100 µm; 
means ± SEM; n=2 mice/region). 
 
 
3.3. Hippo signalling in Casp8∆int mice 
The homeostasis of the intestinal epithelium is maintained by a complex interaction of 
multiple signaling pathways. Unlike the Notch pathway that is inactive in differentiated 
cells, the Hippo pathway is active in differentiated cells. Activation of the Hippo 
pathway through cell-cell contact leads to phosphorylation of the downstream effector 
of Yes-associated protein (YAP) by the LAT1/2 kinases. Phosphorylated YAP (pYAP) 
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remains in the cytoplasm and inhibits its proliferative and anti-apoptotic function in 
the nucleus, which is mediated by its binding to TEAD transcription factors (Zhao et 
al., 2007; Basu et al., 2003; Zhao et al., 2008). In contrast, during inhibiton of Hippo 
signalling, YAP translocates into the nucleus and forms complexes with various 
transcription factors that promote transcription of numerous target genes. It results in 
an expansion of undifferentiated stem cells and an absence of all secretory lineages 
(Camargo et al., 2007; Zhou et al., 2011). Under normal conditions, YAP protein is 
found in the crypts of the small intestine and colon. It is dispensable for intestinal 
homeostasis (Cai et al. 2010). Despite this, an increase in YAP protein is required for 
intestine regeneration in response to injury (Ren et al., 2010).  
To examine the role of Hippo signalling in Casp8 deficient intestine, relative protein 
levels of YAP and phosphorylated YAP were analyzed using Western blotting. The 
YAP protein level was significantly increased in small intestine of Casp8∆int mice 
compared to control mice (Fig. 3.7-A). In colon of Casp8∆int mice, an increase of YAP 
protein level was also detected, but it was not significant. In contrast, phosphorylated 
YAP protein level was slightly decreased in the intestine of Casp8∆int mice compared 
to control mice (Fig. 3.7-B). Consistent with this finding, the analysis of relative 
YAP/pYAP ratio was showed that the relative YAP was dramatically increased in 
Casp8 deficient intestine, despite the small decrease in pYAP protein level (Fig. 3.7-
C). These results suggest that Hippo signaling remains inactive in Casp8 deficient 
intestine compared to control littermates. 
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Figure 3.7. Down-regulation of Hippo signalling in Casp8∆int. (A) Increased YAP 
protein was observed in Casp8∆int intestine compared to controls (Duo: Duodenum, Je: 
Jejunum, pr.Il: proximal Ileum, ter.ll: terminal lleum). (B) pYAP expression was decreased in 
small intestine of Casp8∆int mice. (C) Comparison between YAP and pYAP in the absence 
and presence of Casp8. Values were normalized to GAPDH expression and reported as fold 
change compared to control (means ± SEM; n=3 mice/region; *p<0,05; **p<0,01; 
***p<0,001).  
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3.4. Intestinal Casp8-Notch cross talk - In vitro study 
3.4.1. Casp8 knockdown in Caco2 cells 
Transmission of Notch signalling through the cytoplasm requires a γ-secretase-
mediated cleavage event to release the Notch intracellular domain (NICD) from the 
membrane (Fig. 1-4). In order to further study the mechanism of Notch regulation of 
Casp8 gene expression, the γ-secretase inhibitor (GSI) dibenzazepine (DBZ) was 
utilized to inhibit Notch signalling in vitro in a cell line model. Caco2 cells, a human 
colon adenocarcinoma cell line was chosen as cell line model as it is one of the most 
widely used intestine cell models for in vitro studies of intestinal barrier function. 
These cells exhibit similar properties to enterocytes including having microvilli and 
intracellular junctions, but they lack the crypt-villus axis and mucus producing goblet 
cells (Artursson and Karlsson, 1991; Quaroni and Hochmann, 1996). 
For Casp8 gene knockdown Caco2 cells were treated with siRNA. Successful 
knockdown was confirmed by Western blot analysis and qRT-PCR (Fig. 3.8-A).  
After knockdown of Casp8, dose-dependency of Notch inhibition with DBZ treatment 
in Casp8 deficient Caco2 cells (Caco2
∆Casp8) was tested using a range of DBZ 
concentrations. As standard dose 10µM of DBZ was selected for further analysis. 
Effective Notch disruption in Caco2
∆Casp8 was identified by expression analysis of the 
Notch target genes Hes1 and Math1. Caco2
∆Casp8 showed decreased mRNA levels of 
Math1 compared to negative siRNA-treated cells (Casp8∆scramble). This result 
indicates the up-regulation of Notch activity in Casp8 deficient Caco2. After DBZ 
treatment, significant increased Math1 was observed in Caco2
ΔCasp8 cultures. As 
expected, mRNA levels of Hes1 were decreased in this model compared to control 
cells, but not significantly changed by GSI treatment (Fig. 3.8-B). 
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Figure 3.8. Analysis of Casp8 knockdown efficiency and Notch inhibition in 
Caco2 cells. (A) Successful knockdown of Casp8 using siRNA was identified by Western 
blot and qRT-PCR. (B) Notch target genes Math1 and Hes1 were analyzed by qRT-PCR in 
Caco2
∆Casp8. Values were normalized to β-actin (protein expression) and cyclophilin (mRNA 
expression). Control: untreated Caco2; Casp8
∆scramble: scramble siRNA treated Caco2; 
Caco2
∆Casp8: Casp8 siRNA treated Caco2 (means ± SEM; n=2-3; *p<0,05). 
 
 
3.4.2. Effect of GSI on secretory differentiation of Caco2
∆Casp8 
Next, the GSI-mediated induction of secretory cell differentiation in Caco2
∆Casp8 was 
investigated.  The expression analysis revealed that mRNA levels of the early goblet 
cell marker Tff3 was lower in Caco2
∆Casp8 than in Casp8∆scramble. After DBZ treatment, 
Tff3 mRNA levels were not changed in both culture systems. However, increased 
protein expression of mature goblet cell marker GCNT3 in DBZ-treated Caco2
∆Casp8  
was observed when compared to in vehicle-treated Caco2
∆Casp8, indicating increased 
differentiation to the goblet lineage. Interestingly, in control Casp8∆scramble, GCNT3 
expression was decreased after DBZ treatment (Fig. 3.9-A).  
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In addition, no difference in protein expression of the mature Paneth cell marker 
calnexin was detected in Caco2
∆Casp8 and Casp8∆scramble. Calnexin expression showed 
also no change in response to DBZ treatment in both cell culture systems.  In 
contrast, we observed lower expression of another Paneth cell marker, procryptdin 
precursors MMP7 in Caco2
∆Casp8 than in Casp8∆scramble. After DBZ treatment, MMP7 
expression was significantly increased in Caco2
∆Casp8 (Fig. 3.9-B). These data 
indicate that Notch inhibition was positively correlated with the Casp8 dependent 
secretory cell differentiation. 
 
 
 
Figure 3.9. GSI-mediated induction of secretory cell differentiation in 
Caco2
ΔCasp8. (A) Expression of goblet cell markers GCNT3 (protein) and Tff3 (mRNA) was 
quantified by Western blot analysis and qRT-PCR in Caco2
ΔCasp8 after DBZ treatment. (B) 
Activation of Paneth cell markers Calnexin (protein) and MMP7 (mRNA) was measured by 
Western blot and qRT-PCR in DBZ-treated Caco2
ΔCasp8. Values were normalized to β-actin 
(protein expression) and cyclophilin (mRNA expression). Control: untreated Caco2; 
Casp8∆scramble: scramble siRNA treated Caco2; Caco2
∆Casp8: Casp8 siRNA treated Caco2 
(means ± SEM; n=2-3; *p<0,05). 
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3.5. Intestinal Casp8-Notch cross-talk - In vivo study 
3.5.1. Notch disruption in Casp8∆int mice 
Active Notch signalling has been shown to play a potential role in the regulation of 
cell lineage determination in the Casp8 deficient intestinal epithelium (Chapter 3.2 
and 3.4). Since valuable insight has been gained through the use of in vitro cells lines 
the mechanism was further studied using an in vivo model. The secretory cell lineage 
in the Casp8∆int was analysed to determine if Notch inhibition was associated with a 
corresponding induction in goblet and Paneth cell differentiation.  
Effective disruption of Notch signalling was achieved in mice treated with a 20 μM/kg 
dose of DBZ, as shown by an altered intestinal expression of the Notch target genes 
Hes1 and Math1 compared to vehicle-injected mice. DBZ-treated Casp8∆int model 
exhibited significantly reduced Hes1 mRNA expression (proximal ileum 2,1-fold and 
terminal ileum 1,9-fold) and increased Math1 mRNA expression (proximal ileum 30-
fold and terminal ileum 63-fold) compared to vehicle-treated Casp8∆int, demonstrating 
effective Notch inhibition. Compared to vehicle-treated Casp8f/f mice, an increase in 
Math1 mRNA expression and a decrease in Hes1 mRNA expression in DBZ-treated 
Casp8f/f mice were observed. Additionally, analysis of Hes1 and Math1 between 
Casp8∆int and Casp8f/f intestine treated with DBZ showed a dramatic difference in 
mRNA abundance, suggesting more effective Notch disruption in Casp8∆int mice than 
Casp8f/f mice (Fig. 3.10). These data showed that Notch signalling was inhibited and 
that the secretory differentiation program had been activated.  
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Figure 3.10. Effective Notch disruption in GSI-treated intestine. Expression of the 
Notch signalling target genes Hes1 and Math1 was analyzed by qRT-PCR indicating that 
Notch signalling was effectively inhibited in both mice treated with DBZ. Values were 
normalized to GAPDH expression and reported as fold change compared to control (means 
± SEM; n=3 mice/region; *p<0,05; **p<0,01; ****p<0,0001). 
 
 
3.5.2. Macroscopical analysis of GSI-treated Casp8∆int mice  
In previous studies, abnormally up-regulated Notch activity was found in Casp8 
deficient intestine compared to Casp8f/f mice, leading to the lack of Paneth or goblet 
cells. Thus, the next investigation aimed to identify Notch-responsive cells by 
analysis of secretory cell markers in Casp8∆int mice after Notch inhibition. Notch 
signalling was disrupted by treatment with the GSI dibenzazepine (DBZ) in mice.  
As shown in Figure 3.11, a change in weight and mortality in GSI-treated mice was 
observed. Interestingly, an increase in body weight was found in Casp8∆int mice from 
day 8 after DBZ administration (Fig. 3.11-B). Survival rate of these mice was also 
enhanced (about 50%) (Fig.3.11-A). The colon length of Casp8∆int mice was much 
shorter as compared to Casp8f/f mice. This finding is in accordance with the greater 
loss of body weight in Casp8∆int mice. However, the colon of DBZ-treated Casp8∆int 
mice was significantly longer when compared to the vehicle-treated Casp8∆int mice 
(Fig. 3.11-C).  
Control Casp8∆f/f mice did not lose weight when treated with vehicle, whereas when 
treated DBZ there was a slight drop in weight from day 8 on (Fig. 3.11-B). They also 
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displayed an about 50% enhanced mortality rate (Fig. 3.11-A). The small intestine 
and colon of DBZ-treated Casp8∆f/f mice were shorter in length compared to the 
vehicle-treated Casp8∆f/f mice (Fig. 3.11-C).  
 
 
 
 
 
Figure 3.11. Change in body weight and mortality of DBZ-treated Casp8∆int 
mice. (A) Survival analysis of Casp8∆int and control Casp8f/f mice after DBZ treatment 
(n=4/group). (B) Average body weights of both Casp8∆int and Casp8f/f mice after DBZ 
treatment (age 33 days; n=5/ vehicle-treated group; n=3/DBZ-treated group). (C) 
Representative pictures of Casp8∆int and Casp8f/f mice treated with DBZ or vehicle. 
  
 
3.5.3. Reduction of inflammation in GSI-treated Casp8∆int 
Treatment with GSI to block Notch signalling has been shown to change intestinal 
inflammation features of Casp8∆int mice.  As shown in Figure 3.12, a significant 
reduction of TNF-α mRNA measured by qRT-PCR in the small intestine of Casp8∆int 
mice after DBZ treatment was observed. The mRNA level of IL-1β was also 
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decreased in the small intestine of DBZ-treated Casp8∆int mice compared to controls, 
but not significant. In contrast, there were no changes in mRNA expression of both 
pro-inflammatory cytokines in the intestine of DBZ-treated Casp8f/f when compared to 
vehicle-treated Casp8f/f mice. 
 
 
 
Figure 3.12. Effect of DBZ treatment on TNF-α and IL-1β expression. Cytokine 
levels of TNF-α and IL-1β were measured by qRT-PCR in the intestine from Casp8∆int and 
Casp8f/f mice treated or not treated with DBZ, and data were normalized to GAPDH. In 
Casp8∆int mice significantly reduced mRNA levels of TNF-α after DBZ treatment was 
observed (means ± SEM of three mice per group, *p<0,05; **p<0,01; ***p<0,001).  
 
 
3.5.4. Increased differentiation of secretory lineages in GSI-treated mice 
3.5.4.1. Emergence of Paneth-like cells in DBZ-treated Casp8∆int mice 
Next, changes in secretory cell number were observed in DBZ-treated models. A 
dramatic expansion of Paneth-like cells was observed by H&E staining and by 
increased numbers of cells staining for lysozyme production at the bottom of crypts in 
the small intestine (Fig.3.13-A). The colon is generally devoid of Paneth cells 
expression. Interestingly, however, lysozyme-positive cells were observed in both 
DBZ-treated colons. Paneth cell marker lysozyme showed weakly immune-positive 
cells in DBZ-treated Casp8f/f colon. In contrast, Casp8∆int colon had increased 
numbers of intensely-stained cells (Fig.3.13 -A). 
In accordance with the expansion of Paneth-like cells, cryptdin-1 mRNA levels were 
significantly increased in the terminal ileum of DBZ-treated Casp8∆int mice, with levels 
up to 20-fold higher than in vehicle-treated Casp8∆int mice. In addition, mRNA 
expression of Paneth cell antimicrobial genes such as cryptdins, Agn4, MMP7 and 
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lysoyzme was increased in DBZ-treated Casp8∆int mice compared to vehicle-treated 
Casp8∆int mice, but these were not statistical significant (Fig. 3.13-C). Relative protein 
expression of Paneth cell marker calnexin was slightly increased in DBZ-treated 
Casp8∆int mice compared to in vehicle-treated Casp8∆int mice, but it was not 
significantly changed (Fig. 3.13-B).  
Interestingly, expression of cellular markers including cryptdin-1, Agn4, MMP7, 
lysoyzme and calnexin for Paneth cells was slightly decreased in DBZ-treated 
Casp8f/f mice compared to in vehicle-treated Casp8f/f mice (Fig. 3.13-B,C). Together, 
these data suggest that Paneth-like cells were expanded in response to DBZ-
treatment and that Casp8 deficient intestine showed more apparent effects compared 
to Casp8f/f intestine. 
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Figure 3.13. Emergence of Paneth-like cells in the intestine and colon of DBZ-
treated Casp8∆int mice. (A) H&E staining and immunostaining for lysozyme demonstrated 
increased numbers of lysozyme-positive cells (arrows, brown cytoplasmic stain) in Casp8∆int 
and Casp8f/f intestine after DBZ treatment (scale bar 200 µm). Lysozyme-positive cells were 
also apparent in the Casp8∆int colon compared to Casp8f/f colon (inset shows single crypt at 
higher magnification x63, scale bar 30 µm). (B) Expression of calnexin in bowel segments of 
Casp8∆int mice and control littermates. Western blot analysis of calnexin expression was 
slightly increased in the small intestine of DBZ-treated Casp8∆int mice compared to vehicle-
treated Casp8∆int. Values were normalized to GAPDH expression and reported as fold 
change compared to control. (means ± SEM; n=2 mice/region). (C) qRT-PCR analysis of 
Paneth cell markers in the gut of Casp8∆int and control mice after DBZ treatment. Values 
were normalized to GAPDH expression. n.d. not determined (means ± SEM; n=3 
mice/region; *p<0,05; **p<0,01). 
 
 
3.5.4.2. Increased goblet-like cell in DBZ-treated Casp8∆int mice  
Alcian blue-PAS stained Mucin expression was increased in small intestine and  
colon of all DBZ-treated models, similar to the expansion of goblet cells shown by 
increased Muc2 immunostaining (Fig. 3.14-A). DBZ-treated Casp8∆int mice exhibited 
the highest increase in Muc2 protein levels in small intestine by Western blotting 
analysis compared to vehicle-treated Casp8∆int mice (Fig. 3.14-B).  
The mRNA of Muc2 showed similar result like Muc2 protein expression; mRNA 
expression of Muc2 was 33-fold up-regulated in the terminal ileum of DBZ-treated 
Casp8∆int compared to vehicle-treated Casp8∆int mice. However, protein and mRNA 
levels of Muc2 in the colon were not changed in DBZ-treated Casp8∆int compared to 
vehicle-treated Casp8∆int mice. In contrast, DBZ-treated Casp8f/f showed significantly 
increased Muc2 mRNA expression in the colon compared to vehicle-treated Casp8f/f. 
As an additional measure of goblet cell markers, mRNA expression of GCNT3, Tff3 
and KLF4 was analysed. Casp8∆int mice treated with DBZ had significantly increased 
levels of Tff3 in the small intestine (3-fold increases in the proximal ileum and 5-fold 
increases in the terminal ileum) when compared to vehicle-treated Casp8∆int mice. 
GCNT3 mRNA was also 3-fold increased in the distal colon. The mRNA levels of 
KLF4 were found to be decreased in Casp8 deficient intestine, but did not reach 
statistical significance. However, there was no significant difference in the Tff3 and 
KLF4 levels in Casp8f/f mice following DBZ-treatment (Fig. 3.14-C). Thus, these 
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findings demonstrate that Casp8-Notch cross talk regulates the program of intestinal 
differentiation to goblet-like cells throughout the entire intestine.  
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Figure 3.14. Induction of goblet-like cell differentiation in DBZ-treated Casp8∆int 
mice. (A) DBZ treatment led to an increase in Alcian blue/PAS- and Muc2-positive goblet 
cells in the intestine of Casp8∆int mice and control littermates (scale bar 200 µm). (B) Western 
blot analysis for Muc2 in Casp8∆int mice and controls. Values were normalized to GAPDH 
expression (means ± SEM; n=3 mice/region; *p<0,05; ***p<0,001). (C) qRT-PCR analysis of 
goblet cell markers (Muc2, GCNT3, Tff3, KLF4) mRNA abundance in the intestine. Values 
were normalized to GAPDH expression (means ± SEM; n=2-3 mice/region; *p<0,05; 
**p<0,01; ***p<0,001; ****p<0,0001).  
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3.5.4.3. Increased goblet/Paneth progenitor cell development in GSI-treated 
Casp8∆int mice 
Paneth cells were present as a punctate stain due to localization in secretory 
granules and also as a diffuse cytoplasmic stain in the intestine. However, the pattern 
of lysozyme staining in DBZ-induced Paneth cells was more diffuse throughout the 
cytoplasm, suggesting that a change in secretory granules had occurred. In addition, 
DBZ-induced Paneth cells were co-stained for lysozyme and Muc2 (Fig. 3.15-A). 
Moreover, DBZ-treated Casp8 deficient intestine exhibited increased intensity and 
altered cellular distribution of staining when compared to DBZ-treated controls. These 
data suggest that Notch inhibition in the absence of Casp8 may stimulate the 
development of goblet/Paneth progenitor cells, not mature Paneth or goblet cells.  
Kamal et al. (2001) also reported the expression of goblet cell marker Muc2 in 
goblet/Paneth progenitors due to small amonts of mucus in their cytoplasm, which 
can also be stained with Alcian blue/PAS.  
To further understand the cellular feature of goblet/Paneth progenitors in DBZ-treated 
intestine, the expression levels of Gfi1, a Notch-mediated transcription factor 
responsible for directing cell fate to goblet/Paneth cell or enteroendocrine pathway 
was analysed (Shroyer et al., 2005). Gfi1 mRNA levels were decreased up to 19-fold 
in the terminal ileum of Casp8∆int mice compared to control littermates. After DBZ 
treatment, however, Gfi1 expression was increased in the small intestine and colon of 
both DBZ-treated Casp8∆int and Casp8f/f mice compared to vehicle-treated groups. 
DBZ-treated Casp8f/f mice also showed 22-fold increases of Gfi1 expression in the 
proximal colon (Fig. 3.15-B). These studies show that loss of Casp8 in the intestine, 
and thus increased Notch, lead to disruption of goblet/Paneth progenitor 
differentiation.  
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Figure 3.15. Expansion of progenitor cells in GSI-treated of Casp8∆int mice. (A) 
Inhibition of Notch-induced goblet/Paneth progenitor cells in Casp8∆int mice. Representative 
lysozyme/Muc2-staining, co-localizing with secretory granules (arrows) at the crypt bottom of 
Casp8∆int mice (scale bar 25 µm). (B) mRNA expression of goblet/Paneth progenitor cell 
marker Gfi1 was measured by qRT-PCR. The expression in the small intestine of Casp8∆int 
mice was decreased compared to controls. DBZ-treated intestine showed increased Gfi1 
mRNA levels compared to vehicle-treated groups. Values were normalized to GAPDH 
expression (means ± SEM; n=2 mice/region; **p<0,01). 
 
 
3.6. Changes in intestinal permeability of GSI-treated Casp8∆int mice 
Notch inhibition in Casp8 deficient intestine has been shown to induce intestinal 
secretory cells which lead to mucin secretion and antimicrobial peptides production to 
maintain intestinal barrier functions. Furthermore, Casp8∆int and Casp8f/f mice 
showed some phenotypic difference including body weight and mortality after GSI 
treatment. Here, it was examined if Casp8-Notch cross-talk may act at the luminal, 
mucosal or submucosal levels, to enhance intestinal permeability in Casp8∆int mice.  
Excretion of FITC-dextran was measured in all mice groups treated with vehicle or 
DBZ. Our results showed significant decreases of FITC levels in the serum of DBZ-
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treated Casp8∆int mice compared to vehicle-treated Casp8∆int mice. After 1h 
administration, intestinal permeability to FITC was 4-fold lower in DBZ-treated 
Casp8∆int mice than in vehicle-treated Casp8∆int mice. Furthermore, with 4h of DBZ 
treatment, FITC levels were 5-fold decreased in Casp8∆int mice compared to vehicle-
treated Casp8∆int mice. On the other hand, there were no changes in intestinal 
permeability to FITC in Casp8f/f mice treated with vehicle or DBZ (Fig.3.16). Taken 
together, these findings suggest that inhibition of active Notch leads to a dramatic 
reduction of increased intestinal permeability in the absence of Casp8.  
 
 
 
Figure 3.16.  DBZ treatment causes decreased gut permeability in Casp8∆int 
mice. Intestinal permeability to 4kDa FITC-dextran was evaluated in Casp8∆int and Casp8f/f 
animals after DBZ treatment. FITC levels in the serum were significantly decreased in DBZ-
treated Casp8∆int compared to in vehicle-treated Casp8∆int mice (means ± SEM; n=3 
mice/group; **p<0,01; ***p<0,001) 
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4. Discussion 
The intestinal mucosa consists of different types of epithelial cells in specific barrier 
functions. Epithelial cells produce antimicrobial agents and mucins in controlling 
surface-associated bacterial populations. Thus, the regulation of intestinal epithelial 
homeostasis is important for the maintenance of the defensive barrier functions. 
Disruption of intestinal barrier function is associated with the pathogenesis of IBDs 
such as Chron’s disease and Ulcerative colitis. Several studies have been reported 
that multiple molecular pathways are involved in the regulation of intestinal epithelial 
cell homeostasis. They include Casp8, Notch, and Hippo signaling pathways. 
Therefore, the interactions between these molecular mechanisms are essential to 
understand gastrointestinal diseases. 
 
 
4.1. Microbiome in the gut 
Interaction between intestinal epithelial cells and microbiome plays an important role 
in the regulation of the mucosal immune system. Mucus-adherent microbes 
communicate with the host mucosal immune system through interactions with 
antigen-presenting cells, namely dendritic cells, macrophages and B-cells (Rossi et 
al., 2011). Specific cell receptors such as Toll-like receptors (TLRs) and nucleotide-
binding oligomerization domain (NOD)-like receptors detect pathogen-associated 
molecular patterns, leading to both innate and adaptive immune responses (Sartor, 
2006; Fukata et al., 2013; Van den Abbeele et al., 2011). Among these mechanisms 
is the production of pro-inflammatory cytokines or chemokines, which is increased in 
IBD. 
The GI tract harbors a diverse array of microorganisms, including bacteria, Archae, 
yeast, fungi and viruses (Eckburg et al., 2005; Grill et al., 2006). Of these, bacteria 
have been studied the most.  Recent studies examining rRNA gene sequences have 
revealed that the complex gut-microbiota corresponds to a limited number of bacterial 
phyla, which include Firmicutes, Bacteroidetes, Proteobacteria, Actinobacteria, 
Verrucomicrobia, and Fusobacteria, with Firmicutes and Bacteroidetes as dominant 
phyla (Eckburg et al., 2005). Among them, Firmicutes contains all butylate-producing 
bacteria such as Faecalibacterium prausnitzii (F. prausnitzii), which have been shown 
to increase epithelial barrier function at low concentrations (Eckburg et al., 2005; 
Mariadason et al., 1999; Peng et al., 2007).  
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There is significant individual-to-individual variation in the gut microbiota composition. 
In addition, the presence and function of bacteria varies at different sites of the 
intestine, due to physiological differences along the gastrointestinal tract (Zoetendal 
et al., 2002; Wang et al., 2003).The small intestine is the main site for the digestion of 
foods and absorption of nutrients. Bile and pancreatic secretion restrict the bacterial 
density in the proximal small intestine (O'Hara and Shanahan, 2006). Duodenum and 
jejunum mainly contain acid-tolerant lactobacilli and streptococci (Hayashi et al., 
2005; Wang et al., 2005). The distal small intestine harbors a more diverse 
microbiota containing Firmicutes (Booijink et al., 2007; Wang et al., 2005). Even if the 
bacterial diversity is very high in the colon, it contains the few dominant phyla such as 
Firmicutes (Clostridium and Faecalibacterium), Bacteroidetes and Proteobacteria 
(Hong et al., 2011; Shen et al., 2010; Walker et al., 2011).  
 
Bacteria that colonize the intestinal tract include commensal and pathogenic bacteria. 
Commensal bacteria most likely live in a symbiotic state with the host, which it 
provides benefits. In contrast, some bacteria have been implicated as the pathogen 
of IBD.  Animal studies showed that colitis did not develop in germ-free environment, 
but rather after exposure to intestinal microorganisms (Sartor et al., 2004). An 
increased abundance of E. coli has been detected in mucosal tissues from ileal CD 
patients when compared to their healthy twins (Darfeuille-Michaud et al., 2004; Sokol 
et al., 2006; Willing et al., 2009).  
Additionally, an imbalance (dysbiosis) between beneficial and harmful bacteria in the 
intestinal microbiota has been associated with IBD (Baumgart et al., 2007; 
Manichanh et al., 2006; Scanlan et al., 2006; Seksik et al., 2003). Biopsy analyses 
have shown no significant differences in the mucosa-associated bacteria between 
injured and healthy samples in UC patients (Sokol et al., 2007). However, a 
decreased number of the mucosa-associated bacteria including Bacteroides and 
Lactobacillus were found in CD patients compared to normal controls (Ott et al., 
2004). A decrease in the abundance of F. prausnitzii was also found in ileal CD 
(Sokol et al., 2008). Swidsinski et al. (2008) reported that F. prausnitzii numbers were 
lower in CD patients than in UC and healthy controls (Swidsinski et al., 2008). Finally, 
in twin studies, ileal CD had a dramatically lower abundance of F. prausnitzii 
compared to healthy co-twins (Willing et al., 2009). This bacterium is functionally 
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important as a producer of butyrate, which exhibits anti-inflammatory effects in 
intestinal epithelial cells (Pryde et al., 2002). In addition, the mucus-associated 
bacteria including Clostridium, Ruminococcus and Lactobacillus may affect the 
intestinal barrier function through cross-feeding. IBD patients had a lower diversity of 
bacteria in the colon mucus than healthy people (Walker et al., 2011), while patients 
with colorectal adenomas had a higher density of mucus-associated bacteria, 
Bacteroidetes than healthy people. Thus, alteration in the bacterial composition in the 
intestine may affect the barrier function (John et al., 2011). Recently, modulation of 
the gut microbiota through the administration of probiotics is considered to have 
beneficial effects on human health. They may affect other bacteria in the gut 
microbiota through cross-feeding process and consequently probiotic treatment may 
lead to effects in terms of intestinal integrity. 
 
In summary, increased E.coli along the intestine and an altered intestinal permeability 
has been observed in CD patients (Hilsden et al., 1996). The ileal CD is associated 
with a deficiency in the release of anti-microbial peptides (Wehkamp et al., 2005). 
Our animal model also showed increased intestinal permeability and a deficiency of 
Paneth cells in the small intestine mucosa.  Thus, we need to further investigate 
specific alteration and disturbances in the microbiota of Casp8-deficient intestine 
before and after GSI treatment.  
In addition, Sokol et al. (2008 & 2009) reported that the bacterial count of Firmicutes, 
particularly F. prausnitzii, in the ileal CD patients was significantly reduced (Sokol et 
al., 2008; Sokol et al., 2009). This bacterium has gained much attention recently due 
to its anti-inflammatory effects on cellular and colitis models. F. prausnitzii cells 
reduced the severity of 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in a 
mouse model (Sokol et al., 2008; Sokol et al., 2009). Also, in vitro stimulation by F. 
prausnitzii of peripheral blood mononuclear cells resulted in a significant reduction of 
the secretion of pro-inflammatory cytokine IL-12 and increased the levels of anti-
inflammatory cytokine IL-10 (Sokol et al., 2008). These anti-inflammatory effects are 
associated with reduced secreted metabolites butyrate capable of the blocking NF-kB 
activation (Sokol et al., 2008; Sokol et al., 2009; Daly et al., 2012; Louis et al., 2009). 
Therefore, the administration of probiotics such as F. prausnitzii in our Casp8∆int mice 
seems a further approach to counteract the imbalance in the microbiota, which may 
lead to intestinal inflammation.  
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4.2. Susceptibility of Casp8∆int to IBD 
Disruption of intestinal integrity or altered intestinal permeability is connected to IBD. 
Intestinal integrity - defined as condition with an intact intestinal barrier - is modulated 
by IEC proliferation, differentiation and apoptosis, Tight Junction proteins (TJ) and 
mucus layer formation. Compared to intestinal integrity, intestinal permeability is 
considered as condition where the passage of molecules across the IEC layer is 
possible. Thus, it can be affected by the IEC including TJ complexes, but does not 
cover the mucus layer. Which cames first, a defect in intestinal barrier or the disease 
itself, is not known. For example, CD patients show a barrier defect before clinical 
disease. An E.coli infection through increased intestinal permeability may lead to a 
defect intestinal barrier, causing disease onset (Turner and Griffiths, 2009). It seems 
that increased permeability is caused by inflammation (Al-Sadi et al., 2009). Pro-
inflammatory cytokine TNF-α was shown to induce apoptosis (Ewaschuk et al., 2008; 
Mankertz et al., 2009; Schulzke et al., 2006) and modifications to TJ complexes such 
as occludin and claudin-1 (Ewaschuk et al., 2008). Hence, it leads to increased 
intestinal permeability. To study a risk factor for IBD in Casp8∆int mice, therefore, both 
conditions, intestinal integrity and intestinal permeability, are subject to investigation.  
In our studies, we identified disruption of secretory cells differentiation and decreased 
mucins production in Casp8∆int mice, suggesting impaired intestinal integrity (Chapter 
3.1.3). Furthermore, abnormal increased intestinal permeability was confirmed in 
Casp8∆int mice by FITC-dextran analysis (Chapter 3.1.4). Also, up-regulation of TNF-
α and IL-1β mRNA was detected (Chapter 3.1.2). These factors are might be 
responsible for the high mortality rates seen in Casp8∆int mice (Chapter 3.1.1), 
indicating that intestinal Casp8 deficiency is associated with the pathogenesis of 
IBDs.  
 
 
4.3. Casp8-Notch crosstalk in the intestine 
Our mice lacking intestinal Casp8 showed disrupted differentiation of secretory 
lineages. Since Notch signaling regulates cell fate selection between absorptive and 
secretory cells in the intestine (van Es et al., 2005; Yang et al., 2001; Shroyer et al., 
2007), the expression of Notch target genes in our mice model were analyzed to 
identify a possible interaction between Casp8 and Notch. The finding was that Casp8 
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deficient intestine showed up-regulated Notch activity (Chapter 3.2). In addition, 
differentiation of secretory lineages in Casp8 deficient intestine was induced by Notch 
inhibition using GSI (Chapter 3.5). 
We found that goblet/Paneth progenitor cells emerge in DBZ-treated intestine. This 
evidence points out that the emergence of these progenitor cells could results from 
co-expression of genes that are expressed in mature Paneth cells and in goblet cells. 
Additionally, after DBZ-treatment increased levels of goblet/Paneth progenitor marker 
Gif1 were confirmed (Chapter 3.5.4.3).  
Our results are supported by studies about progenitor cell mechanism. According to 
these studies, goblet/Paneth progenitor cells exhibit smaller secretory granules than 
mature Paneth or goblet cells and contain small amounts of mucin (Andreu et al., 
2005; van Es JH et al., 2005; Calvert et al., 1998). Co-expression of target genes of 
mature Paneth (MMP7, cryptdins) and goblet cells (Muc2) was also shown (Kamal et 
al., 2011; Andreu et al., 2005; van Es JH et al., 2005). Interestingly, these progenitor 
cells were increased in the T. spiralis infection model and seemed to be in regulating 
host immune response to pathogenic infection (Kamal et al., 2011).  
 
Another interesting result is that DBZ-treated Casp8 deficient intestine demonstrated 
increased expression of both Paneth and goblet cell markers compared to untreated 
Casp8 deficient intestine. In contrast, DBZ-treated control mice showed decreased 
expression of Paneth cell marker and increased expression of goblet cell markers 
compared to untreated control mice (Chapter 3.5.4). These findings support our idea 
that Casp8 plays a crucial role in the differentiation of the Paneth cell lineage. The 
immune function of progenitor cells resulted in reduced intestinal inflammation 
(Chapter 3.5.3) and decreased intestinal permeability in Casp8∆int mice (Chapter 3.6), 
which led to enhanced survival rates of DBZ-treated Casp8∆int mice (Chapter 3.5.2). 
Further analysis, including the functional examination of bactericidal activity of DBZ-
induced progenitor cells in Casp8 deficient model, will be required in order to verify 
this potential connection.  
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4.4. Regional specific effects of DBZ in the intestine 
In this study, regional intestinal differences in secretory cell expression of mice 
untreated and treated with DBZ were reported. The finding can be explained by a 
number of factors that take part in regulation of secrertory cell formation.  
First, Paneth cell-derived antimicrobial agents play an important role in intestinal 
immune homeostasis (Selsted et al., 1985; Zasloff et al., 2002). Here, five different 
antimicrobial peptides were analyzed demonstrating a higher expression in distal 
intestine than in proximal intestine. This result is associated with the density of 
colonizing bacteria in the intestine, depending on intestinal function. In general, the 
distal part of the intestine contains greater numbers of bacteria, thus antimicrobial 
peptides are expressed in a higher number in this region. α-defensin is a principal 
antimicrobial peptide associated with the innate immunity system (Ayabe et al., 
2000). In mice, Paneth cell α-defensin termed cryptdins (cryptdin-1 to -6) displays a 
distinct pattern of expression along the intestine. Although Paneth cells of the distal 
intestine are morphologically similar to those in the proximal intestine, cryptdin-4 
mRNA is detected with very low levels in the proximal intestine and occurs at 
maximal levels in terminal ileum (Ouellette et al., 1999). In contrast, cryprdin-1 mRNA 
levels are equivalent throughout the small intestine (Ouellette et al., 1999). Thus, 
Paneth cells might not be equal through the entire intestine which could be an 
indication that there are signaling pathways regulating this difference. 
Additionally, in adult mice the Paneth cell mRNAs for MMP7 and lysoyzme are co-
expressed with cryptdins (Ouellette et al., 1989). Their expression does not require 
direct bacterial exposure (Satoh et al., 1988; Ayabe et al., 2000). However, the 
expression of Agn4 proteins is induced by inflammation and intestinal microbes 
(Hooper et al., 2003). Moreover, compared with other antimicrobial peptides, 
lysozyme and Calnexin are expressed not only in Paneth cells, but also in other cells. 
Macrophages and neutrophils express lysoyzme (Satoh et al., 1988; Coutinho et al., 
1998; Stamp et al., 1992), stem cells and endocrine cells express Calnexin (Gassler 
et al., 2002). Calnexin expression might be dependent on the stage of Paneth cell 
differentiation (Gassler et al., 2002). Thus, more studies are needed in order to 
understand the mechanism by which Paneth cells control the release of their 
granules in an environment that is challenged by bacteria or other factors. 
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The intestinal regional differences are also apparent in goblet cell differentiation. 
Mature goblet cells secret a number of proteins including Muc2, TFF3, GCNT3 and 
KLF4. Although they are expressed almost exclusively by goblet cells throughout the 
small and large intestine, the greatest expression is found in the terminal ileum and 
colon, leading to the thick mucus layer. Tff3 generally co-localizes with Muc2 (Wright 
et al., 2001). However, Tff3 was down-regulated in hyperplastic polyps, sessile 
serrated adenomas and traditional serrated adenomas, although Muc2 expression 
was preserved (Mochizuka et al., 2007). Therefore, further investigations are required 
to analyze the region-specific expression of secretory cells within the gastrointestinal 
tract.  
 
Second, it has been reported that the activity of Notch signaling does not appear to 
be uniform throughout the intestine (Vooijs et al., 2007). In Cre-mediated ligand-
induced Notch 1 receptor proteolysis mice, higher frequency of crypts was observed 
in the proximal intestine than the distal intestine in the activation of Notch signaling 
(Vooijs et al., 2007). It suggests that Notch signaling could lead to differential 
sensitivity to GSI treatment in the intestine.  
Third, since several signaling pathways contribute to maintain intestinal homeostasis, 
complex interactions of them could lead to differential effects of DBZ in the intestine. 
As shown in Chapter 3.3, inactive Hippo signaling is associated with intestinal Casp8 
deficient phenotype. Hippo signaling is generally involved in regulating IEC 
differentiation, indicating the interaction with Notch signaling. In addition, alteration in 
Wnt signaling is essential for Paneth cell differentiation. Intestinal Sox9 deficient 
mice, a target of Wnt signaling showed loss of Paneth cells (Mori-Akiyama et al., 
2007; Bastide et al., 2007). Furthermore, active Wnt signaling in APCmin mice was 
shown to activate Paneth cell genes in the colon and to result in Paneth-like cells on 
the villus (Andreu et al., 2005; van Es JH et al., 2005). These induced Paneth cells in 
the APCmin mouse did not have typical secretory granules suggesting that they might 
not be fully differentiated (Andreu et al., 2005).  
Together, the increased rate of Paneth-like or goblet-like cells demonstrates that 
Notch might function in distinct intestinal regions and that interacting factors might be 
regionally distributed throughout the intestine. In addition, the interaction of Notch 
signaling with Hippo and Wnt signaling pathways seems to regulate secretory cell 
differentiation in the intestine. 
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4.5. Notch effects on cell death in Casp8 deficient intestine 
Gunther et al. (2011) has reported that a deficiency of Casp8 plays a critical role in 
regulating necroptosis of intestinal epithelial cells. They showed increased 
necroptosis in the terminal ileum and Casp8 dependent intestinal inflammation, which 
is associated with the pathogenesis of Chron s´ disease.  
Our mouse model lacking intestinal Casp8, however, showed increased cell death in 
the small intestine and colon (Fig.4.1). Differences between these prior observations 
and our data could be explained by the use of different mouse models. In animal 
research facilities, experimental animals are divided into germfree, gnotobiotes, SPF 
(specific pathogen free) and conventional animals with respect to organism control 
and breeding facility. Our knockout mouse strains were bred and maintained in a 
SPF facility. Thus, the difference between the study by Gunther et al and our findings 
could be caused by different intestinal phenotype due to gut microbial influence. 
 
In our study, we demonstrated the crosstalk between Casp8 and Notch in disruption 
of intestinal secretory cell differentiation. Inhibition of abnormal Notch activity in 
Casp8∆int mice using DBZ led to down-regulation of pro-inflammatory cytokines 
levels. Furthermore, the intestinal permeability of Casp8∆int mice significantly 
reduced, suggesting the possibility to improve intestinal barrier function via inhibition 
of abnormal Notch activity. Therefore, we examined whether the alterations in the 
secretory cells elicited by DBZ were accompanied by alterations in the apoptotic 
compartments. Here, cell death in the intestine was detected by TUNEL staining. 
Surprisingly, Casp8∆int mice showed an increase of TUNEL positive cells after Notch 
inhibition (Fig. 4.1). These TUNEL signals might indicate apoptosis of immune cells, 
not intestinal epithelial cells as Droy-Dupre et al. (2012) reported that DBZ did not 
modify the number of apoptotic cells, either in the surface epithelium or at the base of 
crypts. Further characterization of these cells by FACS is evaluating (in collaboration 
with Dr. T. Clahsen, Institute of Pediatric, University Hospital Aachen). 
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Figure 4.1. Increased cell death after DBZ treatment. Sections from the small 
intestine of DBZ-treated or untreated Casp8∆int mice were stained for TUNEL to analyze 
changes in cell death rate. After DBZ treatment TUNEL positive signals were increased in 
the lamina propria (scale bar 50 µm).  
 
 
4.6. Casp8-Notch crosstalk in intestinal tumors 
Patients with inflammatory bowel disease are at increased risk of colorectal cancer 
(CRC) (Ekbom et al., 1990; Eaden et al., 2001; Jess et al., 2005). Risk factors 
include young age at IBD onset, long disease duration, severity of inflammation, and 
genetic susceptibility. The mechanisms leading to neoplasia and subsequent 
progression to cancer are not fully identified. However, the development of CRC in 
IBD shows many similarities. The precursor lesions in CRC and IBD are defined by 
specific morphologic changes of the mucosal cells (dysplasia). They are graded 
according to the severity of mucosal cell changes; normal mucosa/non-dysplasia, 
indefinite for dysplasia, low and high grade dysplasia, cancer (Riddell et al., 1983). In 
addition, since chronic inflammation has been linked to carcinogenesis (Itzkowitz et 
al., 2004), Casp8-dependent phenotype in the intestine is an interesting topic to 
study the relationship between IBD and intestinal tumors. 
Hes1, a target gene of active Notch signaling is over-expressed in human colorectal 
cancer (Fre et al., 2009; Sikandar et al., 2010; Reedijk et al., 2008) and in mouse 
adenomas (van ES et al., 2005; Vooijs et al., 2007). In contrast, Math1, 
transcriptional repressor of Hes1, is down-regulated in CRC (Leow et al., 2004; 
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Bossuyt et al., 2009). These findings suggest the potential to reduce adenoma cell 
occurrence by Notch inhibition. Indeed, van ES et al. (2005) showed that inhibition of 
Notch using GSI in APCmin mice led to the conversion of proliferative adenoma cells 
into goblet cells and decreased adenomas. Additionally, an in vitro assay with human 
colon cancer cells such as HT29, HCT116 or LS174T showed induces apoptosis and 
secretory cell lineage differentiation depending on GSI treatment (Ghaleb et al., 
2008; Sikrandar et al., 2010; Okamoto et al., 2009).  
 
In this study, Caco2 lacking Casp8 showed much lower expression of Math1 
compared to wild-type Caco2 cells. However, Hes1 levels were similar in both cell 
systems. After GSI treatment, Math1 was significantly up-regulated only in 
Caco2
∆Casp8 and differentiation of Paneth-like cells was detected by expression of 
MMP7. However, Calnexin levels were not changed in both cell culture models. 
Gassler et al. (2002) reported that expression of Calnexin was not affected by cellular 
proliferative activity in Caco2. In addition, Caco2
∆Casp8 showed loss of goblet-like cells 
and induced goblet-like cells differentiation after Notch inhibition. Interestingly, Caco2 
wild-type did not lead to the conversion of adenoma cells into goblet-like cells after 
GSI treatment. Thus, Casp8-Notch interaction might contribute to secretory cell 
differentiation in Caco2.  
 
 
4.7. GSI for treatment of Casp8-dependent intestinal disorders  
Several intestinal diseases such as colorectal cancer and IBD display changes in 
proportions of progenitors or secretory cells, depending on Notch signaling (Helmrath 
et al., 2007; Kamal et al., 2001; Gregorieff et al., 2005).  Thus, identification of 
therapeutics that target intestinal Notch signaling would be valuable. Given that γ-
secretase inhibitors prevent Notch receptor activation, they are an important target 
for anti-tumor effects. 
We examined the effect of GSI on Casp8∆int mice that exhibit intestinal inflammation 
phenotype. Consequently, we found increased secretory lineages leading to 
enhanced immune activity in Casp8 deficient intestine. Subsequently, the 
inflammation factor and intestinal permeability of Casp8∆int mice were reduced. In 
correlation with these findings, Casp8∆int mice showed increased body weight and 
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enhanced survival rate (about 50%). Interestingly, however, DBZ-treated control mice 
presented reduced body weight and increased mortality (Chapter 3.5.2). This 
observation seemed to be caused by reduction anti-microbial peptides in the intestine 
of DBZ-treated control mice. However, we could not find any change in inflammation.  
 
Therefore, we investigated the potential cause of increased mortality rate in DBZ-
treated control mice. Since Notch signaling also participates in cellular physiology in 
normal tissue, inactivation of Notch by γ-secretase inhibitors might lead to the 
dysfunction of vital organs (Shih et al., 2006).  
In order to investigate the evidence of increased mortality in control mice, we 
histologically analyzed others organs, finding no significant changes, but slightly 
increased up-regulated immune activity in the lung of DBZ-treated control mice. As 
shown in Fig. 4.2, Naphthol AS-D Chloroacetate esterase staining detected an 
increased number of neutrophil granulocyte in the lung of control mice after DBZ 
treatment. This result might reflect a side effect associated with γ-secretase 
inhibitors. However, this result was not significant and thus we need to further explore 
the cause of mortality in GSI-treated control mice.  
 
 
Figure 4.2. Potential side effect of GSI. Sections from mice were stained by Naphthol 
AS-D Chloroacetate esterase in order to evaluate immune activity in the lung after DBZ 
treatment. The number of neutrophil granulocyte (red) was increased in the lung of DBZ-
treated control mice (scale bar 50 µm).  
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Wong et al. (2004) reported that Notch modulating GSI caused dose-dependent side 
effects in the thymus, spleen and intestine of mice. Notch inhibition resulted in an 
increased number of goblet cells at the expense of adsorptive cells, leading to 
increased mucin in the lumen of the intestine, which consequently caused diarrhea 
(Wong et al., 2004). They also showed erosion of the intestinal epithelium with 
underlying infiltration of inflammatory cells in the lamina propria (Wong et al., 2004). 
These alterations in the intestinal barrier and mucosal immune response might allow 
the decrease in body weight and increase in mortality in mice treated with GSI. 
Interestingly, mice with low-dose GSI had no effect on the gastrointestinal tract 
(Wong et al., 2004). 
 
Additionally, Notch inhibition by GSI resulted in a decrease of the thymocyte number 
and the block thymocyte differentiation in vitro model (Hadland et al., 2001; Doerfler 
et al., 2001). In vivo, GSI treatment induced a profound thymic atrophy of the cortical 
region with a decrease in thymic cellularity, a reduction of the intratymic populations 
and significant depletion of the cortex (Allman et al., 2002; Wong et al., 2004). The 
reduction of thymocyte cell number was a dose-response effect. GSI treatment in the 
mouse study also showed increased of B-cells. This finding suggests that Notch 
inhibition might control B- versus T-cell fate decisions within the lymphocyte stem 
cells in the thymus (Doerfler et al., 2001; Radtke et al., 1999; Schmitt et al., 2003). 
Furthermore, Notch signaling plays a role in marginal zone B-cell development in the 
spleen (Radtke et al., 1999). The number of immature B-cells in the blood was 
increased by the inhibition of splenic B-cell maturation after GSI treatment, although 
this had no effect on splecin cellularity (Wong et al., 2004).  
 
Similar effects caused by a Notch modulator were observed in rat intestine. Searfoss 
et al. (2003) reported that Notch inhibition by GSI caused intestinal goblet cell 
metaplasia in rats and induced adipsin in the gut, which might serve as a toxicity 
marker for the clinical lesion. After GSI treatment, the intestinal phenotype in rat was 
changed, including goblet cell metaplasia, intraluminal mucus, apoptosis of crypt 
epithelial cells, villous stunting and vacuolation of villious epithelia cells (Searfoss et 
al., 2003). In the rat study, small intestinal crypt epithelial cell hyperplasia and large 
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intestinal glandular epithelial hyperplasia were confirmed at all gut levels, except the 
cecum (Milano et al., 2004). 
These data suggest that Notch plays multiple roles in regulating immune system 
function and that blocking Notch signaling by GSI adversely affect the immune 
defense in various organs, causing increased mortality. Thus, we need to monitor 
immune system disorders in our GSI-treated control mice. It will be important to 
measure functional T- and B-cell responses in the intestine, thymus and spleen after 
GSI treatment. 
 
Next, the long-term suppression of Notch signaling caused severe side effects in 
angiogenesis and vascular diseases. In a mouse model study, Dou et al. (2008) 
showed that Notch inhibition accelerated choroidal neovascularization (Dou et al. 
2008). Disruption of Notch in adult mice led to spontaneous angiogenesis in the 
retina, liver and lung. Notch modulating by GSI negatively regulated angiogenesis in 
normal adults, which contributes to homeostasis of normal vasculature and induced 
the development of lethal hemorrhage and vascular tumors (Duo et al., 2008; Yan et 
al., 2010; Liu et al., 2011). In this case, it is insufficient to assess the lesions by 
hisotological analysis. 
 
Additionally, the loss of Notch activity could lead to the development of squamous 
cell carcinoma (SCC) in the skin and lung (Demehri et al., 2009; Nicolas et al., 2003; 
Wang et al., 2011). SCCs are the most common ectodermal cancers, which arise 
from uncontrolled differentiation of squamous cells in the skin, lung and digestive 
tract (Goon et al., 2009; Madan et al., 2010). Notch receptors are expressed in the 
skin and activation of Notch promotes the differentiation of keratinocytes (Okuyama 
et al., 2004). In mouse studies, Notch inhibition induced extensive epidermal 
hyperplasia and spontaneously developed cutaneous basal cell carcinoma (BCC) 
and squamous cell carcinoma (SCC) (Nicolas et al, 2003). A recent study has 
reported that loss-of-function in Notch plays a crucial role in developing lung SCCs 
(Wang et al., 2011). Inactivating Notch increased the risk of developing lung SCCs, 
as well as head and neck SCCs (Wang et al., 2011; Agrawal et al., 2011; Stransky et 
al., 2011). These findings indicate that Notch acts as a tumor suppressor and 
blocking Notch signaling may induce squamous epithelial malignancies. Thus, GSI 
treatment may lead to even more problematic effects, which develop tumors. This 
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mechanism might contribute to the increased mortality of DBZ-treated control mice in 
our study.  
 
The potential side effects from GSI, which may be associated with the increased 
mortality rate in DBZ-treated control mice, include immune-related disorders in the 
spleen, thymus and intestine, vascular disease, lethal hemorrhage and SCCs in the 
skin and lung. To study the cause of the mortality rate in DBZ-treated control mice, as 
described above, we histologically analyzed various organs such as the intestine, 
skin, lung and spleen, yet did not found any altered histological features. Given that 
vascular disease and lethal hemorrhage cannot be detected by histological analysis, 
further studies are necessary to assess these lesions by other methods.  
 
The most important finding in our study was that Casp8 knockout mice did not cause 
these potential side effects from GSI, which were observed in control mice. In 
Casp8∆int mice, Notch inhibition led to improved intestinal barrier function, resulting in 
an increased survival rate. After GSI administration, we found the histological 
induction of goblet/Paneth progenitor cells in both Casp8∆int and control mice. 
However, their quantification analysis presented that the expression of goblet cell 
markers was increased in both Casp8∆int and control mice, whereas the expression of 
Paneth cell markers was only increased in Casp8∆int mice. Moreover, expression 
levels of Paneth and goblet cell markers were much higher in Casp8∆int mice than 
control mice. Thus, Casp8 may play a crucial role for Paneth cell differentiation 
and/or maturation in the intestine via Notch signaling. Loss of Casp8 in the intestinal 
epithelium, it may lead to abnormal Notch activity and consequently promote the 
proliferation of intestinal stem cells, yet disrupt the differentiation of Paneth cells. 
These mechanisms may result in dysfunction of immune reaction in the intestine as 
well as the regulation of intestinal gut microbiomes.  
 
Casp8 knockout mice showed similar intestinal phenotypes such as loss of Paneth 
cells, mucosal inflammation and increased intestinal permeability, which were found 
in Chron’s disease. Therefore, this recent success demonstrates that Casp8-
dependent Notch function may be a potential etiology of IBD. In addition, GSI can be 
effective for the treatment of Casp8-relevante intestinal disorders. Of course, 
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therapeutic application of γ–secretase inhibitors must be multi-factorally considered 
with balancing efficacy and toxicity of γ-secretase inhibitors. We need to further study 
what molecules in Notch signaling interact with Casp8 in detail. By identifying and 
modulating the contributing molecules/factors in this mechanism, it will provide a 
better understanding of IBD pathogenesis.  
 
 
4.8. Similarity of intestinal Casp8 knockout phenotype with YAP1-induced 
dysplasia 
The Hippo pathway plays a crucial role in intestinal repair and tumorigenesis by 
regulating cell proliferation and cell death (Camargo et al., 2007; Cai et al., 2010; 
Ren et al., 2010; Zhou et al., 2011). Under normal conditions, YAP, a Hippo target 
gene, makes no contribution to intestinal epithelial proliferation. However, it is 
required for tissue regeneration caused by injury (Cai et al., 2010). Recent studies 
reported that inhibition of Hippo pathway by YAP led to disruption of intestinal 
epithelial homeostasis, including expansion of stem-like undifferentiated cells and 
absence of secretory lineages (Camargo et al., 2007; Zhou et al., 2011).  
These YAP-induced intestinal phenotypes were similar to the intestinal features of 
our Casp8∆int mice, thus we assumed that Casp8-deficient phenotype in the intestine 
might be associated with a deficiency in Hippo signaling. In order to address this 
possibility, we analyzed the expression of Hippo target genes, YAP and pYAP in 
Casp8 deficient intestine. Western blot analysis revealed over-expression of YAP 
protein in Casp8∆int mice compared to levels in control littermates. Furthermore, 
reduction of pYAP in Casp8∆int mice (Chapter 3.3) was observed. These findings 
suggest that down-regulated Hippo contributes to intestinal Casp8-deficient 
phenotype. 
 
Moreover, some studies showed that the inactivation of Hippo pathway to inhibit 
intestinal epithelial differentiation is attributed to the activation of Notch signaling 
(Camargo et al., 2007; Zhou et al., 2011). In YAP over-expressed transgenic mice 
increased expression of a Notch target gene Hes1 was found. After DBZ treatment, 
the intestinal dysplasia was suppressed in these transgenic mice with decreased 
proliferation and the presence of goblet cells (Camargo et al., 2007). This result 
suggests that YAP stimulates Notch signaling. Thus, the link between these 
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pathways in Casp8 deficient intestine for maintaining intestinal homeostasis needs to 
be further investigated.  
Increased nuclear accumulation of YAP is commonly found in colorectal cancer, 
because colon cancer is associated with the consequent ongoing regenerative 
response (Steinhardt et al., 2008; Zhou et al., 2009; Terzic et al., 2010; Wang et al., 
2011; Zhou et al., 2011). Therefore, an interesting study objective would be to 
analyze the contribution of Hippo signalling inactivation in Casp8∆int mice to 
tumorigenesis in the intestine.  
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Abbreviations 
 
ADAM                       A Disintegrin And Metalloproteinase         
AMPs                       Antimicrobial peptides 
APCmin/+                     a point mutation at the Apc gene; mouse, a model for the human  
                                 condition, Familial Adenomatous Polyposis  
APS                          Ammoniumperoxodisulfat 
BCC                          basal cell carcinoma  
BZ                             benodiazepine  
BSA                          Bovine Serum Albumin 
Casp8                       Caspase-8 
Casp8∆int                   intestinal epithelium-specific constitutive Casp8 homozygous  
                                 knockout  mice 
Casp8f/f                     cre-negative littermate control mice 
Casp8∆scramble            negative siRNA-treated cells 
Caco2
∆Casp8               Casp8 deficient Caco2 cells  
CD                            Crohn’s disease 
cDNA                        complementary DNA 
Co-A                         co-activators 
CRC                          colorectal cancer  
Csf1                           colony stimulating factor 1 
CSL                           CBF1, Suppressor of Hairless, Lag-1 
DAPI                          4',6-diamidino-2-phenylindole 
DTT                           Dithiothreitol 
DMSO                       Dimethyl sulfoxide 
DAB                          diaminobenzidine 
DBZ                          dibenzazepine  
EphB3                       Ephrin type-B receptor 3 protein 
Fbw7                         a member of F-box family proteins  
FADD                        Fas-Associated protein with Death Domain 
FITC-dextran             Fluorescein isothiocyanate-dextran 
F. prausnitzii              Faecalibacterium prausnitzii  
GAPDH                     glyceraldehyde 3-phosphate dehydrogenase 
GCNT3                      glucosaminyl (N-acetyl) transferase 3 
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Gfi1                        growth factor independent 1 
GIT                         gastrointestinal tract  
GSI                         γ‑secretase inhibitors  
h                             hour 
Hes1                       hairy and enhancer of split 1 
H&E                        Hematoxylin and eosin  
HRP                        horseradish peroxidase  
IBD                          Inflammatory bowel disease  
IECs                        Intestinal epithelial cells 
IgG                          Immunglobulin G 
IL                             Interleukin 
Kb                           kilobase 
KLF4                       Kruppel-like factor 4  
LCM                        Laser capture microdissection MAML1 
M                            molar 
µ                             micro 
min                         minute 
MMP7                    matrix metalloproteinase-7 
MOM                      Mouse-on-mouse  
Muc                        mucin 
Neurog3                 neurogenin 3 
NICD                      Notch intracellular domain  
OD                         optical density 
PAS-AB                 periodic acid Schiff-alcian blue 
PBS                       Phosphate buffered saline 
RIP                        receptor-interacting protein kinase 
PPAR                    peroxisome proliferator-activated receptor 
qRT-PCR              quantitative real time PCR 
rpm                       Rotations per Minute 
RT                         room temperature 
pYAP                    phosphorylated YAP 
SCC                      squamous cell carcinoma 
siRNA                   small interfering RNA 
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Spdef                    SAM pointed domain ETS factor  
sPLA2                   secretory Phospholipase A2 
TA cells                 transit amplifying progenitors  
TBST                    mixture of Tris-Buffered Saline and Tween 20 
TEMED                 Tetramethylethylenediamine 
Tff3                       Trefoil factor 3  
TJ                         Tight Junction proteins 
TNF-α                   tumor necrosis factor-alpha 
TUNEL                 TdT-mediated dUTP nick end labeling 
UC                        Ulcerative colitis 
WT                        wild type 
YAP                      Yes-associated protein 
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